zurück Frame öffnen
 .
 Anhang II


Index-Nr.Internationale chemische BezeichnungEG-NummerCAS-NummerEinstufungKennzeichnungSpezifische Konzentrationsgrenzen, M-FaktorenAnmerkungen
Gefahrenklasse, Gefahrenkategorie und GefahrenkodierungKodierung der GefahrenhinweisePiktogramm, Kodierung der SignalworteKodierung der GefahrenhinweiseKodierung der ergänzenden Gefahrenmerkmale
003-003-00-5(2-methylpropyl)lithium;
isobutyllithium		440-620-2920-36-5Water-react. 1
Pyr. Liq. 1
Skin Corr. 1A
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1		H260
H250
H314
H336
H400
H410		GHS02
GHS05
GHS07
GHS09
Dgr		H260
H250
H314
H336
H410		EUH014  
005-007-00-2boric acid; [1]
boric acid, crude natural, containing not more than 85 per cent
of H3BO3 calculated on the dry weight [2]		233-139-2 [1]
234-343-4 [2]		10043-35-3 [1]
11113-50-1 [2]		Repr. 1BH360FDGHS08
Dgr		H360FD Repr. 1B; H360FD: C > 5,5 % 
005-008-00-8diboron trioxide;
boric oxide		215-125-81303-86-2Repr. 1BH360FDGHS08
Dgr		H360FD Repr. 1B; H360FD: C > 3,1 % 
005-011-00-4disodium tetraborate, anhydrous;
boric acid, disodium salt; [1]
tetraboron disodium heptaoxide, hydrate; [2]
orthoboric acid, sodium salt [3]		215-540-4 [1]
235-541-3 [2]
237-560-2 [3]		1330-43-4 [1]
12267-73-1 [2]
13840-56-7 [3]		Repr. 1BH360FDGHS08
Dgr		H360FD Repr. 1B; H360FD: C > 4,5 % 
005-011-01-1disodium tetraborate decahydrate;
borax decahydrate		215-540-41303-96-4Repr. 1BH360FDGHS08
Dgr		H360FD Repr. 1B; H360FD: C > 8,5 % 
005-011-02-9disodium tetraborate pentahydrate;
borax pentahydrate		215-540-412179-04-3Repr. 1BH360FDGHS08
Dgr		H360FD Repr. 1B; H360FD: C > 6,5 % 
005-013-00-5diethylmethoxyborane425-380-97397-46-8Pyr. Liq. 1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4		H250
H332
H312
H302
H373**
H314
H317
H413		GHS02
GHS05
GHS08
GHS07
Dgr		H250
H332
H312
H302
H373**
H314
H317
H413		   
005-014-00-04-formylphenylboronic acid438-670-587199-17-5Skin Sens. 1H317GHS07
Wng		H317   
005-015-00-61-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)414-380-4140681-55-6Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H302
H318
H317
H412		GHS05
GHS07
Dgr		H302
H318
H317
H412		   
005-016-00-1tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate431-370-5-Aquatic Chronic 4H413-H413   
005-017-00-7sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]		239-172-9 [1]
231-556-4 [2]		15120-21-5 [1]
7632-04-4 [2]		Oxid. Sol. 2
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1		H272
H360Df
H302
H335
H318		GHS03
GHS05
GHS08
GHS07
Dgr		H272
H360Df
H302
H335
H318		 Repr. 1B; H360Df: C > 9 %
Repr. 1B; H360D: 6,5 % < C < 9 %
Eye Dam. 1; H318: C > 22 %
Eye Irrit. 2; H319: 14 % < C < 22 %		 
005-017-01-4sodium perborate; [1]
sodium peroxometaborate; [2]
sodium peroxoborate;
[containing > 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]		239-172-9 [1]
231-556-4 [2]		15120-21-5 [1]
7632-04-4 [2]		Oxid. Sol. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1		H272
H360Df
H331
H302
H335
H318		GHS03
GHS06
GHS05
GHS08
Dgr		H272
H360Df
H331
H302
H335
H318		 Repr. 1B; H360Df: C > 9 %
Repr. 1B; H360D: 6,5 % < C < 9 %
Eye Dam. 1; H318: C > 22 %
Eye Irrit. 2; H319: 14 % < C < 22 %		 
005-018-00-2perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]		239-172-9 [1]
234-390-0 [2]
231-556-4 [3]		13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]		Repr. 1B
STOT SE 3
Eye Dam. 1		H360Df
H335
H318		GHS05
GHS08
GHS07
Dgr		H360Df
H335
H318		 Repr. 1B; H360 Df: C > 14 %
Repr. 1B; H360D: 10 % < C < 14 %
Eye Dam. 1; H318: C > 36 %
Eye Irrit. 2; H319: 22 % < C < 36 %		 
005-018-01-Xperboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing > 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]		239-172-9 [1]
234-390-0 [2]
231-556-4 [3]		13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]		Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1		H360Df
H332
H335
H318		GHS05
GHS08
GHS07
Dgr		H360Df
H332
H335
H318		 Repr. 1B; H360Df: C > 14 %
Repr. 1B; H360D: 10 % < C < 14 %
Eye Dam. 1; H318: C > 36 %
Eye Irrit. 2; H319: 22 % < C < 36 %		 
005-019-00-8perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]		234-390-0 [1]
234-390-0 [2]
231-556-4 [3]		11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]		Oxid. Sol. 3
Repr. 1B
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1		H272
H360Df
H302
H335
H318		GHS03
GHS05
GHS08
GHS07
Dgr		H272
H360Df
H302
H335
H318		 Repr. 1B; H360Df: C > 9 %
Repr. 1B; H360D: 6,5 % < C < 9 %
Eye Dam. 1; H318: C > 22 %
Eye Irrit. 2; H319: 14 % < C < 22 %		 
005-019-01-5perboric acid, sodium salt; [1]
perboric acid, sodium salt, monohydrate; [2]
perboric acid (HBO(O2)), sodium salt, monohydrate; [3]
sodium peroxoborate;
[containing > 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]		234-390-0 [1]
234-390-0 [2]
231-556-4 [3]		11138-47-9 [1]
12040-72-1 [2]
10332-33-9 [3]		Oxid. Sol. 3
Repr. 1B
Acute Tox. 3 *
Acute Tox. 4 *
STOT SE 3
Eye Dam. 1		H272
H360Df
H331
H302
H335
H318		GHS03
GHS06
GHS05
GHS08
Dgr		H272
H360Df
H331
H302
H335
H318		 Repr. 1B; H360Df: C > 9 %
Repr. 1B; H360D: 6,5 % < C < 9 %
Eye Dam. 1; H318: C > 22 %
Eye Irrit. 2; H319: 14 % < C < 22 %		 
006-091-00-3propineb (ISO);
polymeric zinc propylenebis(dithiocarbamate)		-9016-72-2Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1		H332
H373**
H317
H400		GHS08
GHS07
GHS09
Wng		H332
H373**
H317
H400		   
006-092-00-9tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate425-420-598737-29-2Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
006-093-00-42,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)427-180-7-Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H317
H400
H410		GHS07
GHS09
Wng		H302
H317
H410		   
006-094-00-XO-isobutyl-N-ethoxy carbonylthiocarbamate434-350-4103122-66-3Flam. Liq. 3
Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2		H226
H350
H340
H302
H373**
H317
H411		GHS02
GHS08
GHS07
GHS09
Dgr		H226
H350
H340
H302
H373**
H317
H411		   
006-095-00-5fosetyl-aluminium (ISO);
aluminium triethyl triphosphonate		254-320-239148-24-8Eye Dam. 1H318GHS05
Dgr		H318   
006-096-00-0chlorpropham (ISO);
isopropyl 3-chlorocarbanilate		202-925-7101-21-3Carc. 2
STOT RE 2 *
Aquatic Chronic 2		H351
H373**
H411		GHS08
GHS09
Wng		H351
H373**
H411		   
006-097-00-61-phenyl-3-(p-toluenesulfonyl)urea424-620-113909-63-2Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3		H302
H373**
H412		GHS08
GHS07
Wng		H302
H373**
H412		   
006-098-00-1tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate429-170-8134575-17-0Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1		H302
H373**
H318
H317		GHS05
GHS08
GHS07
Dgrg		H302
H373**
H318
H317		   
006-099-00-7N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;
3-({[(4-methylphenyl)sulfonyl]carbamoyl} amino)phenyl 4-methylbenzenesulfonate		432-520-2232938-43-1Aquatic Chronic 2H411GHS09H411   
006-101-00-6reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];
N-(4-[[4-[[(phenylamino)carbonyl]amino] phenylmethyl]phenyl]-N'-cyclohexylurea;
N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]		423-070-8-Aquatic Chronic 4H413-H413   
006-102-00-1O-hexyl-N-ethoxycarbonylthiocarbamate432-750-3-Carc. 1B
Muta. 1B
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2		H350
H340
H302
H373**
H317
H411		GHS08
GHS07
GHS09
Dgr		H350
H340
H302
H373**
H317
H411		   
006-103-00-7N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea445-760-8-Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H334
H400
H410		GHS05
GHS08
GHS09
Dgr		H318
H334
H410		 M=100 
007-028-00-2hydroxylammonium nitrate236-691-213465-08-2Expl. 1.1 ****
Carc. 2
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1		H201
H351
H311
H302
H373**
H319
H315
H317
H400		GHS01
GHS06
GHS08
GHS09
Dgr		H201
H351
H311
H302
H373**
H319
H315
H317
H400		   
007-029-00-8diethyldimethylammonium hydroxide419-400-595500-19-9Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1A		H312
H302
H314		GHS05
GHS07
Dgr		H312
H302
H314		   
012-004-00-Xaluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate422-150-1-Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
013-010-00-5hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)430-650-4151841-65-5Aquatic Chronic 2H411GHS09H411   
014-033-00-32-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica419-030-4125804-20-8Flam. Liq. 2
Eye Irrit. 2
STOT SE 3		H225
H319
H336		GHS02
GHS07
Dgr		H225
H319
H336		   
014-034-00-93-hexylheptamethyltrisiloxane428-700-51873-90-1Acute Tox. 4 *
Aquatic Chronic 4		H332
H413		GHS07
Wng		H332
H413		   
014-035-00-42-(3,4-epoxycyclohexyl) ethyltriethoxy silane425-050-410217-34-2Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
014-036-00-X(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane405-020-7105024-66-6Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1		H360F***
H400
H410		GHS08
GHS09
Dgr		H360F***
H410		 M=1000 
014-037-00-52-butanone-O,O',O''-(phenylsilylidyne)trioxime433-360-634036-80-1STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3		H373**
H317
H412		GHS08
GHS07
Wng		H373**
H317
H412		   
014-038-00-0S-(3-(triethoxysilyl)propyl) octanethioate436-690-9220727-26-4Skin Sens. 1H317GHS07
Wng		H317   
014-039-00-6(2,3-dimethylbut-2-yl)-trimethoxysilane439-360-2142877-45-0Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3		H315
H318
H412		GHS05
Dgr		H315
H318
H412		   
014-041-00-7N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane445-890-5201290-01-9Acute Tox. 4 *
Skin Sens. 1		H302
H317		GHS07
Wng		H302
H317		   
014-042-00-2reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime)
(3 stereoisomers)		423-010-0-Eye Dam. 1H318GHS05
Dgr		H318   
014-043-00-8reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl)
magnesium (3-15 %),
tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)		432-200-2-Aquatic Chronic 2H411GHS09H411   
014-044-00-33-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane433-050-0-Aquatic Chronic 2H411GHS09H411   
014-045-00-9magnesium sodium fluoride silicate442-650-1-STOT RE 2 *H373**GHS08
Wng		H373**   
015-113-00-0tolclofos-methyl (ISO);
O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate		260-515-357018-04-9Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
015-182-00-7tetraisopropyldichloromethylenebisphosphonate430-630-510596-22-2Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1		H302
H319
H317		GHS06
Wng		H302
H319
H317		   
015-183-00-2(1-hydroxydodecylidene)diphosphonic acid425-230-216610-63-2Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1		H314
H400
H410		GHS05
GHS09
Dgr		H314
H410		   
015-188-00-X(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate425-220-85945-33-5Aquatic Chronic 4H413-H413   
015-190-00-0bis(2,4-dicumylphenyl) neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-
3,9-diphosphaspiro[5.5]undecane		421-920-2154862-43-8Aquatic Chronic 4H413-H413   
015-191-00-6dodecyldiphenyl phosphate431-760-527460-02-2Skin Irrit. 2
Aquatic Chronic 3		H315
H412		GHS07
Wng		H315
H412		   
015-192-00-1tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate432-770-2139189-30-3Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
015-193-00-7triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-
N-methyl-1-butanesulfonamide (1:1)		442-960-7332350-93-3Acute Tox. 3 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H301
H318
H400
H410		GHS05
GHS06
GHS09
Dgr		H301
H318
H410		   
015-194-00-2tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate444-440-5220689-12-3Acute Tox. 4 *
Aquatic Chronic 3		H302
H412		GHS07
Wng		H302
H412		   
015-195-00-8reaction mass of: potassium o-toluenephosphonate;
potassium m-toluenephosphonate;
potassium p-toluenephosphonate		433-860-4-Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3		H319
H317
H412		GHS07
Wng		H319
H317
H412		   
015-196-00-3reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl) phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl) phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl) phosphonate		435-960-3-Carc. 1B
Muta. 1B
Skin Sens. 1		H350
H340
H317		GHS08
GHS07
Dgr		H350
H340
H317		   
015-197-00-9bis(2,4,4-trimethylpentyl) dithiophosphonic acid420-160-9107667-02-7Flam. Liq. 3
Acute Tox. 3 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2		H226
H331
H302
H314
H411		GHS02
GHS06
GHS05
GHS09
Dgr		H226
H331
H302
H314
H411		   
015-198-00-4(4-phenylbutyl)phosphinic acid420-450-586552-32-1Carc. 2
Eye Dam. 1		H351
H318		GHS05
GHS08
Dgr		H351
H318		   
016-092-00-0reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11- undecanedithiol;
4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11- undecanedithiol;
5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11- undecanedithiol		427-050-1-Repr. 1A
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H361f
H315
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H361f
H315
H317
H410		   
016-094-00-1sulfur231-722-67704-34-9Skin Irrit. 2H315GHS07
Wng		H315   
016-097-00-81-amino-2-methyl-2-propanethiol hydrochloride434-480-132047-53-3Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3		H302
H314
H317
H412		GHS05
GHS07
Dgr		H302
H314
H317
H412		   
017-023-00-7[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-
N-(C6-18)-alkyl] trichlorides		425-520-9197179-61-6Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H400
H410		GHS05
GHS09
Dgr		H318
H410		   
022-004-00-1potassium titanium oxide (K2Ti6O13)432-240-012056-51-8Carc. 2H351GHS08
Dgr		H351   
022-005-00-7[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-
tetramethyl-2,4-cyclopentadien-1-
yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium		419-840-8169104-71-6Flam. Sol. 1****
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 4		H228
H314
H317
H413		GHS02
GHS05
GHS07
Dgr		H228
H314
H317
H413		   
024-021-00-Xpotassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-
3,5-disulfonatobenzeneazo-1'-prop-1'-
ene-2,2'-diolato]chromate(III)		425-830-4-Eye Dam. 1H318GHS05
Dgr		H318   
026-003-00-7iron (II) sulfate231-753-57720-78-7Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2		H302
H319
H315		GHS07
Wng		H302
H319
H315		   
026-003-01-4iron(II) sulfate (1:1) heptahydrate;
sulfuric acid, iron(II) salt (1:1), heptahydrate;
ferrous sulfate heptahydrate		231-753-57782-63-0Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2		H302
H319
H315		GHS07
Wng		H302
H319
H315		 Skin Irrit. 2; H315: C > 25 % 
026-004-00-2potassium ferrite430-010-412160-44-0Skin Corr. 1B
Skin Sens. 1		H314
H317		GHS05
GHS07
Dgr		H314
H317		   
027-006-00-6cobalt acetate200-755-871-48-7Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360F***
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360F***
H334
H317
H410		 Carc. 1B; H350i: C > 0,01 %
M=10		1
027-007-00-1zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex425-240-7-Eye Dam. 1
Aquatic Chronic 2		H318
H411		GHS05
GHS09
Dgr		H318
H411		   
027-008-00-7complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-
hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2 < n < 3)		427-390-9-Skin Sens. 1H317GHS07
Wng		H317   
027-009-00-2cobalt nitrate233-402-110141-05-6Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360F***
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360F***
H334
H317
H410		 Carc. 1B; H350i: C > 0,01 %
M=10		1
027-010-00-8cobalt carbonate208-169-4513-79-1Carc. 1B
Muta. 2
Repr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360F***
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360F***
H334
H317
H410		 Carc. 1B; H350i: C > 0,01 %
M=10		1
028-002-01-4nickel powder;
[particle diameter < 1 mm]		231-111-47440-02-0Carc. 2
STOT RE 1
Skin Sens. 1
Aquatic Chronic 3		H351
H372**
H317
H412		GHS08
GHS07
Dgr		H351
H372**
H317
H412		   
028-011-00-6nickel dichloride231-743-07718-54-9Carc. 1A
Muta. 2
Repr. 1B
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H400
H410		GHS06
GHS08
GHS09
Dgr		H350i
H341
H360D***
H331
H301
H372**
H315
H334
H317
H410		 STOT RE. 1; H373: C > 1 %
STOT RE. 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C > 20 %
Skin Sens. 1; H317: C > 0,01 %
M=1		 
028-012-00-1nickel dinitrate; [1]
nitric acid, nickel salt [2]		236-068-5 [1]
238-076-4 [2]		13138-45-9 [1]
14216-75-2 [2]		Ox. Sol. 2
Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H272
H350i
H341
H360D***
H372**
H332
H302
H318
H315
H317
H400
H410		GHS03
GHS05
GHS08
GHS07
GHS09
Dgr		H272
H350i
H341
H360D***
H372**
H332
H302
H318
H315
H317
H410		 STOT RE. 1; H373: C > 1 %
STOT RE. 2; H373: 0,1 % < C < 1 %
Skin Irrit. 2; H315: C > 20 %
Skin Sens. 1; H317: C > 0,01 %
M=1		 
028-013-00-7nickel matte273-749-669012-50-6Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-014-00-2slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate295-859-392129-57-2Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H341
H360D***
H372**
H332
H302
H315
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		 
028-015-00-8slimes and sludges, copper electrolyte refining, decopperised305-433-194551-87-8Carc. 1A
Muta. 2
Repr. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		  H
028-016-00-3nickel diperchlorate;
perchloric acid, nickel(II) salt		237-124-113637-71-3Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410		GHS05
GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H314
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-017-00-9nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]		237-563-9 [1]
239-793-2 [2]		13842-46-1 [1]
15699-18-0 [2]		Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-018-00-4nickel bis(sulfamidate);
nickel sulfamate		237-396-113770-89-3Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-019-00-Xnickel bis(tetrafluoroborate)238-753-414708-14-6Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-021-00-0nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]		222-101-0 [1]
239-946-6 [2]
268-755-0 [3]		3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]		Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-022-00-6nickel di(acetate); [1]
nickel acetate [2]		206-761-7 [1]
239-086-1 [2]		373-02-4 [1]
14998-37-9 [2]		Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H332
H302
H334
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H341
H360D***
H372**
H332
H302
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		E H
028-024-00-7nickel dibenzoate209-046-8553-71-9Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-025-00-2nickel bis(4-cyclohexylbutyrate)223-463-23906-55-6Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		 
028-026-00-8nickel(II) stearate;
nickel(II) octadecanoate		218-744-12223-95-2Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-027-00-3nickel dilactate-16039-61-5Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-028-00-9nickel(II) octanoate225-656-74995-91-9Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H314
H334
H317
H400
H410		GHS05
GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H314
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-029-00-4nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]		233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4]		10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]		Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-030-00-Xnickel hexafluorosilicate247-430-726043-11-8Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-031-00-5nickel selenate239-125-215060-62-5Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-032-00-0nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8]		238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8]		14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]		Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H372**
H334
H317
H410		  H
028-033-00-6diammonium nickel hexacyanoferrate-74195-78-1Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H372**
H334
H317
H410		  H
028-034-00-1nickel dicyanide209-160-8557-19-7Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H372**
H334
H317
H410		EUH032 H
028-035-00-7nickel chromate238-766-514721-18-7Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H372**
H334
H317
H410		  H
028-036-00-2nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)] trinickelate(3-) [5]		244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]		21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]		Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-037-00-8dinickel hexacyanoferrate238-946-314874-78-3Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-038-00-3trinickel bis(arsenate);
nickel(II) arsenate		236-771-713477-70-8Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350
H372**
H317
H410		  H
028-039-00-9nickel oxalate; [1]
oxalic acid, nickel salt [2]		208-933-7 [1]
243-867-2 [2]		547-67-1 [1]
20543-06-0 [2]		Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-040-00-4nickel telluride235-260-612142-88-0Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-041-00-Xtrinickel tetrasulfide-12137-12-1Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-042-00-5trinickel bis(arsenite)-74646-29-0Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-043-00-0cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]		269-051-6 [1]
261-346-8 [2]
- [3]		68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]		Carc. 1A
STOT RE 1
Skin Sens. 1		H350i
H372**
H317		GHS08
GHS07
Dgr		H350i
H372**
H317		  H
028-044-00-6nickel tin trioxide;
nickel stannate		234-824-912035-38-0Carc. 1A
STOT RE 1
Skin Sens. 1		H350i
H372**
H317		GHS08
GHS07
Dgr		H350i
H372**
H317		  H
028-045-00-1nickel triuranium decaoxide239-876-615780-33-3Carc. 1A
STOT RE 1
Skin Sens. 1		H350i
H372**
H317		GHS08
GHS07
Dgr		H350i
H372**
H317		  H
028-046-00-7nickel dithiocyanate237-205-113689-92-4Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		EUH032STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-047-00-2nickel dichromate239-646-515586-38-6Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-048-00-8nickel(II) selenite233-263-710101-96-9Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H372**
H334
H317
H410		  H
028-049-00-3nickel selenide215-216-21314-05-2Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-050-00-9silicic acid, lead nickel salt-68130-19-8Carc. 1A
Repr. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H360Df
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H360Df
H372**
H317
H410		  H
028-051-00-4nickel diarsenide; [1]
nickel arsenide [2]		235-103-1 [1]
248-169-1 [2]		12068-61-0 [1]
27016-75-7 [2]		Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-052-00-Xnickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900		271-853-668610-24-2Carc. 1A
STOT RE 1
Skin Sens. 1		H350i
H372**
H317		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317		  H
028-053-00-5nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]		267-897-0 [1]
238-596-1 [2]
275-897-7 [3]		67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]		Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-054-00-0nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(d-gluconato-O1,O2)nickel; [18]
nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]
(isononanoato-O)(isooctanoato-O)nickel; [22]
(isooctanoato-O)(neodecanoato-O)nickel; [23]
(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]
(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]
(isodecanoato-O)(isooctanoato-O)nickel; [26]
(isodecanoato-O)(isononanoato-O)nickel; [27]
(isononanoato-O)(neodecanoato-O)nickel; [28]
fatty acids, C6-19-branched, nickel salts; [29]
fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]		240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31]		16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]		Carc. 1A
Muta. 2
Repr. 1B
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H341
H360D***
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H341
H360D***
H372**
H334
H317
H410		 STOT RE 1; H372: C > 1 %
STOT RE 2; H373: 0,1 % < C < 1 %
Skin Sens. 1; H317: C > 0,01 %
M=1		H
028-055-00-6nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide phosphate [4]		231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]		7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]		Carc. 1A
STOT RE 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H334
H317
H400
H410		GHS08
GHS09
Dgr		H350i
H372**
H334
H317
H410		  H
028-056-00-1nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]		234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8]		12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]		Carc. 1A
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H372**
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H350i
H372**
H317
H410		  H
028-057-00-7dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]		234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11]		12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11]		Carc. 1A
STOT RE 1
Skin Sens. 1		H350i
H372**
H317		GHS08
GHS07
Dgr		H350i
H372**
H317		  H
028-058-00-2cobalt lithium nickel oxide442-750-5-Carc. 1A
Acute Tox. 2 *
STOT RE 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H350i
H330
H372**
H317
H400
H410		GHS06
GHS08
GHS09
Dgr		H350i
H330
H372**
H317
H410		   
029-014-00-5reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]
bis[phenolate]](2-)N,N',O,O'-copper complex;
2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)] bis[phenolate]]
(2-)N,N',O,O'-copper complex		419-610-7171866-24-3STOT RE 2 *
Aquatic Chronic 2		H373**
H411		GHS08
GHS09
Wng		H373**
H411		   
030-009-00-5zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate417-130-2-Eye Dam. 1
Aquatic Chronic 2		H318
H411		GHS05
GHS09
Dgr		H318
H411		   
030-010-00-02-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt430-740-3-Aquatic Chronic 2H411GHS09H411   
030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9Aquatic Chronic 3H412-H412   
030-015-00-8tetrazinc(2+)bis(hexacyanocobalt(3+)) diacetate440-060-9-Aquatic Chronic 2H411GHS09H411   
040-003-00-4reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride,
dehydrated, basic Zr: DTBS = 1,0: 1,0 to 1,0: 1,5		430-610-6226996-19-6Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
042-005-00-0reaction mass of: mono- and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];
N,N-diorgano dithiocarbamate molybdenum complex		434-240-6-Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
046-001-00-Xtetraammine palladium(II) hydrogen carbonate425-270-0134620-00-1Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H373**
H318
H317
H400
H410		GHS05
GHS08
GHS07
GHS09
Dgr		H302
H373**
H318
H317
H410		   
047-002-00-8polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt416-850-4-Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
050-021-00-4dichlorodioctyl stannane222-583-23542-36-7Acute Tox. 3 *
STOT RE 1
Aquatic Chronic 3		H331
H372**
H412		GHS06
GHS08
Dgr		H331
H372**
H412		   
050-022-00-Xdibutyltin dichloride;
(DBTC)		211-670-0683-18-1Muta. 2
Repr. 1B
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1		H341
H360FD
H330
H301
H312
H372**
H314
H400
H410		GHS06
GHS05
GHS08
GHS09
Dgr		H341
H360FD
H330
H301
H312
H372**
H314
H410		 Skin Corr. 1B; H314: C > 5 %
Skin Irrit. 2; H315: 0,01 % < C < 5 %
Eye Dam. 1; H318: 3 % < C < 5 %
Eye Irrit. 2; H319: 0,01 % < C < 3 %
M=10		 
050-023-00-5reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane		422-920-5-STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H373**
H400
H410		GHS08
GHS09
Wng		H373**
H410		 M=10 
050-024-00-0reaction mass of: tri-p-tolyltin hydroxide;
hexa-p-tolyl-distannoxane		432-230-6-STOT RE 1
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H372**
H302
H315
H318
H317
H400
H410		GHS05
GHS08
GHS07
GHS09
Dgr		H372**
H302
H315
H318
H317
H410		   
064-001-00-8gadolinium(III)sulfite trihydrate456-900-251285-81-5Aquatic Chronic 2H411GHS09H411   
078-010-00-Xtetraammine platinum(II) hydrogen carbonate426-730-3123439-82-7Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3		H302
H318
H412		GHS05
GHS07
Dgr		H302
H318
H412		   
078-011-00-5hydroxydisulfito platinum(II) acid423-310-161420-92-6Acute Tox. 4 *
STOT RE 2 *
Skin Corr. 1A
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3		H302
H373
H314
H334
H317
H412		GHS05
GHS08
GHS07
Dgr		H302
H373
H314
H334
H317
H412		   
078-012-00-0platinum(IV) nitrate/nitric acid solution432-400-1-Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1		H314
H400
H410		GHS05
GHS09
Dgr		H314
H410		   
082-012-00-6barium calcium cesium lead samarium strontium bromide
chloride fluoride iodide europium doped		431-780-4199876-46-5Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2		H302
H373**
H411		GHS08
GHS07
GHS09
Wng		H302
H373**
H411		   
601-070-00-0reaction mass of: branched icosane;
branched docosane;
branched tetracosane		417-050-8151006-58-5Acute Tox. 4 *
Aquatic Chronic 4		H332
H413		GHS07
Wng		H332
H413		   
601-072-00-1reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane;
1-(3-isopropylphenyl)-1-phenylethane;
1-(2-isopropylphenyl)-1-phenylethane		430-690-252783-21-8Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H315
H400
H410		GHS07
GHS09
Wng		H315
H410		   
601-075-00-84,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane418-770-5151882-81-4Carc. 2H351GHS08
Wng		H351   
601-076-00-3ethynyl cyclopropane425-430-16746-94-7Flam. Liq. 2
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3		H225
H315
H318
H412		GHS02
GHS05
Dgr		H225
H315
H318
H412		   
601-077-00-9reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;
1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane		426-510-7196965-91-0Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
601-078-00-4reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)
methyl]bicyclo[2.2.1]heptane;
2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl) methyl]bicyclo[2.2.1]heptane		427-040-5-Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1		H314
H400
H410		GHS05
GHS09
Dgr		H314
H410		   
601-079-00-Xreaction mass of: trans-trans-cyclohexadeca-1,9-diene;
cis-trans-cyclohexadeca-1,9-diene		429-620-3-Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4		H315
H317
H413		GHS07
Wng		H315
H317
H413		   
601-080-00-5reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers;
1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-(sec-butylphenyl-1-phenylethane, mixed isomers		431-100-6-Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
601-081-00-0cyclohexadeca-1,9-diene431-730-14277-06-9Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4		H315
H317
H413		GHS07
Wng		H315
H317
H413		   
601-082-00-6reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo
[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]
hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane		434-420-4-Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H315
H318
H400
H410		GHS05
GHS09
Dgr		H315
H318
H410		   
601-083-00-15-endo-hexyl-bicyclo[2.2.1]hept-2-ene435-000-322094-83-3Asp. Tox. 1
Skin Irrit. 2
Aquatic Chronic 4		H304
H315
H413		GHS08
GHS07
Dgr		H304
H315
H413		   
601-084-00-7reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)		435-180-3-Asp. Tox. 1
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H304
H315
H400
H410		GHS08
GHS07
GHS09
Dgr		H304
H315
H410		   
602-095-00-Xalkanes, C14-17, chloro;
chlorinated paraffins, C14-17		287-477-085535-85-9Lact.
Aquatic Acute 1
Aquatic Chronic 1		H362
H400
H410		GHS09
Wng		H362
H410		EUH066  
602-098-00-62-(3-bromophenoxy)tetrahydro-2H-pyran429-030-657999-49-2Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
602-099-00-13-(4-fluorophenyl)-2-methylpropionylchloride426-370-7-Skin Corr. 1A
Acute Tox. 4 *
Aquatic Chronic 3		H314
H302
H412		GHS05
GHS07
Dgr		H314
H302
H412		EUH014
EUH029		  
602-100-00-5reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane;
(S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane		420-640-8-Aquatic Chronic 3H412-H412   
602-101-00-02-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate427-020-6141772-37-4STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H373**
H317
H400
H410		GHS08
GHS07
GHS09
Wng		H373**
H317
H410		   
602-102-00-61,1,1,3,3-pentafluorobutane430-250-1406-58-6Flam. Liq. 2H225GHS02
Dgr		H225   
602-103-00-11-(chlorophenylmethyl)-2-methylbenzene431-450-141870-52-4Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H315
H400
H410		GHS07
GHS09
Wng		H315
H410		   
602-104-00-71,1,2,2,3,3,4-heptafluorocyclopentane430-710-115290-77-4Aquatic Chronic 3H412-H412   
602-105-00-2sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate422-100-7102061-82-5Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
602-106-00-82-bromo-4,6-difluoroaniline429-430-0444-14-4Acute Tox. 4 *
Aquatic Chronic 2		H302
H411		GHS07
GHS09
Wng		H302
H411		   
602-107-00-33,3,4,4-tetrafluoro-4-iodo-1-butene439-500-233831-83-3Acute Tox. 4 *
Skin Irrit. 2
Aquatic Chronic 2		H302
H315
H411		GHS07
GHS09
Wng		H302
H315
H411		   
602-108-00-9(2,3,5,6-tetrafluorophenyl)methanol443-840-74084-38-2Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1		H302
H319
H317		GHS07
Wng		H302
H319
H317		   
603-109-00-7reaction mass of:
1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;
1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane		425-340-0-Aquatic Chronic 4H413-H413   
603-110-00-2reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane;
trans-2-isobutyl-5-methyl 1,3-dioxane		426-130-1166301-21-9Skin Irrit. 2
Aquatic Chronic 3		H315
H412		GHS07
Wng		H315
H412		   
603-111-00-8reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;
1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane		426-530-6-Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H315
H400
H410		GHS07
GHS09
Wng		H315
H410		   
603-112-00-3cyclopentyl 2-phenylethyl ether428-340-9-Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H315
H400
H410		GHS07
GHS09
Wng		H315
H410		   
603-113-00-96-glycidyloxynapht-1-yl oxymethyloxirane429-960-227610-48-6Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 3		H341
H312
H315
H317
H412		GHS08
GHS07
Wng		H341
H312
H315
H317
H412		   
603-114-00-49-(2-propenyloxy)tricyclo[5.2.1.0(2,6)] dec-3(or-4-)-ene430-830-226912-64-1Skin Irrit. 2
Aquatic Chronic 2		H315
H411		GHS07
GHS09
Wng		H315
H411		   
603-115-00-Xreaction mass of:
O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)		423-580-0-STOT RE 2 *
Aquatic Chronic 4		H373**
H413		GHS08
Wng		H373**
H413		   
603-116-00-5(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride424-740-2138271-16-6Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3		H302
H318
H412		GHS05
GHS07
Dgr		H302
H318
H412		   
603-182-00-5reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide428-630-5-Skin Sens. 1H317GHS07
Wng		H317   
603-188-00-8reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-
1,1,2,4,4,7-hexamethylnaphthalene;
7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene		426-970-9-Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
603-190-00-98,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane424-030-262406-73-9Skin Irrit. 2
Aquatic Chronic 3		H315
H412		GHS07
Wng		H315
H412		   
603-192-00-X(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol423-240-1125474-34-2Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H315
H318
H317
H400
H410		GHS05
GHS07
GHS09
Dgr		H315
H318
H317
H410		   
603-193-00-5disodium 9,10-anthracenedioxide426-030-846492-07-3Skin Corr. 1AH314GHS05
Dgr		H314   
603-194-00-02-(2-aminoethylamino)ethanol;
(AEEA)		203-867-5111-41-1Repr. 1B
Skin Corr. 1B
Skin Sens. 1		H360Fd
H361
H314
H317		GHS05
GHS08
GHS07
Dgr		H360Fd
H361
H314
H317		 STOT SE 3; H335: C > 5 % 
603-200-00-11-pentanol; [1]
3-pentanol [2]		200-752-1 [1]
209-526-7 [2]		71-41-0 [1]
584-02-1 [2]		Flam. Liq. 3
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2		H226
H332
H335
H315		GHS02
GHS07
Wng		H226
H332
H335
H315		   
603-201-00-7(E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol416-120-5-Skin Irrit. 2
Aquatic Chronic 4		H315
H413		GHS07
Wng		H315
H413		   
603-202-00-24,4,5,5,5-pentafluoropentan-1-ol421-360-9148043-73-6Acute Tox. 4 *
Aquatic Chronic 3		H302
H412		GHS07
Wng		H302
H412		   
603-203-00-8(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13 -hexamethyl-4,6-dioxatetracyclo
[6.5.1.01,10.03,7]tetradecane		427-580-1-Skin Irrit. 2H315GHS07
Wng		H315   
603-204-00-3reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;
2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane		428-110-8-Aquatic Chronic 3H412-H412   
603-205-00-9(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride426-200-1172015-79-1STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H372**
H302
H318
H317
H412		GHS05
GHS08
GHS07
Dgr		H372**
H302
H318
H317
H412		   
603-206-00-42,2-dichloro-1,3-benzodioxol426-850-62032-75-9Flam. Liq. 3
Skin Corr. 1A
Acute Tox. 4 *
Skin Sens. 1		H226
H314
H302
H317		GHS02
GHS05
GHS07
Dgr		H226
H314
H302
H317		EUH014  
603-207-00-X2-isobutyl-2-isopropyl-1,3-dimethoxypropane430-800-9129228-21-3Skin Irrit. 2
Aquatic Chronic 2		H315
H411		GHS07
GHS09
Wng		H315
H411		   
603-208-00-51,2-diethoxyethane211-076-1629-14-1Flam. Liq. 2
Repr. 1A
Eye Irrit. 2		H225
H360Df
H319		GHS02
GHS08
GHS07
Dgr		H225
H360Df
H319		EUH019  
603-209-00-0spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50);
reaction mass of 50-95 % of (2R,3aS,5aR,5bS,9S,13S,14R,16aS, 16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-
2,3,4,6-tetradeoxy-β- d-erythropyranosyloxy)-9-ethyl
-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15, 16a,16b-hexadecahydro-14-methyl- 1H-8-oxacyclododeca[b]as-
indacene-7,15-dione and 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,
16bS)-2-(6-deoxy-2,3,4- tri-O-methyl-α-l-mannopyranosyloxy)-13-
(4-dimethylamino-2,3,4,6-tetradeoxy-β- d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,
16a,16b-hexadecahydro- 4,14-dimethyl-1H-8-oxacyclododeca[b]as-
indacene-7,15-dione; [1]
spinosyn A; [2]
spinosyn D [3]		- [1]
- [2]
- [3]		- [1]
131929-60-7 [2]
131929-63-0 [3]		Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410 M=10 
603-210-00-62,4-diethyl-1,5-pentanediol429-310-857987-55-0Eye Dam. 1H318GHS05
Dgr		H318   
603-211-00-12,3-epoxypropyltrimethylammonium chloride ... %;
glycidyl trimethylammonium chloride ... %		221-221-03033-77-0Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H350
H341
H361f***
H312
H302
H373**
H318
H317
H412		GHS05
GHS08
GHS07
Dgr		H350
H341
H361f***
H312
H302
H373**
H318
H317
H412		  B
603-212-00-71,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;
galaxolide; (HHCB)		214-946-91222-05-5Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
603-213-00-22-methoxy-2-methylbutane;
tert-amyl methyl ether		213-611-4994-05-8Flam. Liq. 2
Acute Tox. 4 *
STOT SE 3		H225
H302
H336		GHS02
GHS07
Dgr		H225
H302
H336		   
603-214-00-81,1-diisopropoxycyclohexane413-740-81132-95-2Skin Corr. 1BH314GHS05
Dgr		H314   
603-215-00-31-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)418-330-2162241-33-0Expl. 1.1****
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H201
H302
H373**
H318
H317
H400
H410		GHS01
GHS05
GHS08
GHS07
GHS09
Dgr		H201
H302
H373**
H318
H317
H410		   
603-216-00-9cis-1-amino-2,3-dihydro-1H-inden-2-ol422-660-27480-35-5Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H318
H317
H412		GHS05
GHS07
Dgr		H318
H317
H412		   
603-217-00-42,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite423-560-1161717-32-4Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
603-220-00-01-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol432-890-572955-94-3Aquatic Chronic 4H413-H413   
603-221-00-61-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]		433-580-2214353-17-0Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2		H302
H314
H411		GHS05
GHS07
GHS09
Dgr		H302
H314
H411		   
603-221-01-31-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing > 0,1 % 4-chloroaniline (EC No 203-401-0)]		433-580-2214353-17-0Carc. 1B
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 2		H350
H302
H314
H411		GHS05
GHS08
GHS07
GHS09
Dgr		H350
H302
H314
H411		   
603-222-00-1(2R,3S,4R,5R,7R,9R,10R,11S,12S, 13R)-10-[(4-dimethylamino-
3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]- 2-ethyl-
3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl
-6,14-dioxo-1-oxacyclotetradecane		433-820-6118058-74-5Eye Irrit. 2H319GHS07
Wng		H319   
603-223-00-72-cyclopentylidene cyclopentanol;
1,1'-bi(cyclopentyliden)-2-ol		434-270-16261-30-9Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3		H315
H318
H412		GHS05
Dgr		H315
H318
H412		   
603-224-00-23-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane435-790-1297730-93-9Aquatic Chronic 4H413-H413   
603-225-00-8erythromycin A9-oxime (E);
(3R,4S,5S,6R,7R,9R,11R,12R,13S, 14R)-4-((2,6-didesoxy-
3-C-methyl-3-O-methyl-α- L-ribo-hexopiranosyl)oxy)- 14-ethyl-
7,12,13-trihydroxy-3,5,7,9,11,13- hexamethyl-6-
((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)
oxacyclotetradecan-2-ona-10-oxime (E)		437-070-013127-18-9Aquatic Chronic 2H411GHS09H411   
603-226-00-34,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol444-500-01440-00-2Aquatic Chronic 3H412-H412   
603-227-00-9α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)]
ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl))
ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate		445-060-2203574-04-3****
Aquatic Acute 1
Aquatic Chronic 1		****
H400
H410		****
GHS09
Wng		****
H410		   
603-228-00-4(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
6-fluoro-2-(2-oxiranyl)chromane		419-620-1-Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
603-229-00-Xsodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate420-800-7-Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H315
H318
H317
H400
H410		GHS05
GHS07
GHS09
Dgr		H315
H318
H317
H410		   
603-230-00-52,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan440-030-5-Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 4		H315
H318
H413		GHS05
Dgr		H315
H318
H413		   
603-231-00-0(S)-1,1-diphenyl-1,2-propanediol443-220-6-Aquatic Chronic 3H412-H412   
603-232-00-63,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-
1,5-dioxa-9-aza-spiro[5.5]undecane		444-420-6-Aquatic Chronic 4H413-H413   
603-233-00-1reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-
3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol		444-430-0-Aquatic Chronic 2H411GHS09H411   
603-234-00-7(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6)) undec-5-ene444-480-3-Skin Irrit. 2
Aquatic Chronic 2		H315
H411		GHS07
GHS09
Wng		H315
H411		   
604-071-00-44,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene) diphenol425-600-3110726-28-8Aquatic Chronic 4H413-H413   
604-072-00-X1,2-bis(phenoxymethyl)benzene428-620-010403-74-4Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
604-073-00-5(E)-3-[1-[4-[2-(dimethylamino)ethoxy] phenyl]-2-phenylbut-1-enyl]phenol428-010-482413-20-5Carc. 2
Repr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H351
H360F***
H317
H400
H410		GHS08
GHS07
GHS09
Dgr		H351
H360F***
H317
H410		   
604-074-00-0tetrabromobisphenol-A;
2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol		201-236-979-94-7Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
604-075-00-64-(1,1,3,3-tetramethylbutyl)phenol;
4-tert-octylphenol		205-426-2140-66-9Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H315
H318
H400
H410		GHS05
GHS09
Dgr		H315
H318
H410		 M=10 
604-076-00-1phenolphthalein201-004-777-09-8Carc. 1B
Muta. 2
Repr. 2		H350
H341
H361f***		GHS08
Dgr		H350
H341
H361f***		 Carc. 1A; H350: C > 1 % 
604-077-00-72-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol419-750-998809-58-6Aquatic Chronic 4H413-H413   
604-079-00-84,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol428-970-413595-25-0Repr. 2
Skin Sens. 1
Aquatic Chronic 2		H361f***
H317
H411		GHS08
GHS09
Wng		H361f***
H317
H411		   
604-080-00-34-fluoro-3-trifluoromethylphenol432-560-061721-07-1Acute Tox. 4 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Chronic 2		H332
H314
H317
H411		GHS05
GHS07
GHS09
Dgr		H332
H314
H317
H411		   
604-081-00-91,1-bis(4-hydroxyphenyl)-1-phenylethane433-130-51571-75-1Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
604-082-00-42-chloro-6-fluoro-phenol433-890-82040-90-6Muta. 1B
Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2		H340
H361f***
H302
H314
H317
H411		GHS05
GHS08
GHS07
GHS09
Dgr		H340
H361f***
H302
H314
H317
H411		   
604-083-00-X4,4'-sulfonylbisphenol, polymer with ammonium chloride (NH4Cl),
pentachlorophosphorane and phenol		439-270-3260408-02-4Aquatic Chronic 4H413-H413   
604-084-00-51-ethoxy-2,3-difluorobenzene441-000-4121219-07-6Acute Tox. 4 *
Aquatic Chronic 3		H302
H412		GHS07
Wng		H302
H412		   
604-087-00-1reaction mass of:
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with
4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene) bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with
4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene) bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with
4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene) bisphenol		433-640-8-Pyr. Sol. 1
Aquatic Chronic 4		H250
H413		GHS02
Dgr		H250
H413		EUH044  
604-089-00-22-methyl-5-tert-butylthiophenol444-970-7-Flam. Liq. 3
Repr. 2
STOT RE 2 *
Asp. Tox. 1
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1		H226
H361d***
H373**
H304
H319
H315
H317
H336
H400
H410		GHS02
GHS08
GHS07
GHS09
Dgr		H226
H361d***
H373**
H304
H319
H315
H317
H336
H410		   
605-023-00-55-chloro-2-(4-chlorophenoxy)phenol429-290-03380-30-1Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H400
H410		GHS05
GHS09
Dgr		H318
H410		   
605-024-00-02-bromo-5-hydroxy-4-methoxybenzaldehyde426-540-02973-59-3Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
605-032-00-43-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal425-370-493957-50-7Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
605-033-00-Xreaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;
3,7,11-trimethyl-trans-6,10-dodecadienal		425-910-932480-08-3Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H315
H400
H410		GHS07
GHS09
Wng		H315
H410		   
605-034-00-5reaction mass of:
(1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)] decane-3-carbaldehyde;
(1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)] decane-3-carbaldehyde;
(1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)] decane-4-carbaldehyde		429-860-9-Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
605-035-00-0(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis
(1-methoxymethyl)pyridin-3-yl)prop-2-enal		426-330-9177964-68-0Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 4		H319
H317
H413		GHS07
Wng		H319
H317
H413		   
605-036-00-62-bromomalonaldehyde430-470-62065-75-0Acute Tox. 4 *
Eye Dam. 1		H302
H318		GHS05
GHS07
Dgr		H302
H318		   
605-037-00-1trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde		421-800-1120578-03-2Aquatic Chronic 4H413-H413   
605-038-00-73-methyl-5-phenylpentan-1-al433-900-055066-49-4Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2		H302
H315
H317
H411		GHS07
GHS09
Wng		H302
H315
H317
H411		   
605-039-00-23,4-dihydroxy-5-nitrobenzaldehyde441-810-8116313-85-0Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1		H302
H318
H317		GHS05
GHS07
Dgr		H302
H318
H317		   
606-074-00-6reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-
1,2,8,8-tetramethylnaphthalene;
(2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene		425-570-1-Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
606-090-00-31-[3-[(dimethylamino)methyl] -4-hydroxyphenyl]ethanone430-920-173096-98-7Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3		H302
H318
H412		GHS05
GHS07
Dgr		H302
H318
H412		   
606-093-00-X5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one414-470-395885-13-5Acute Tox. 4 *
Aquatic Chronic 3		H302
H412		GHS07
Wng		H302
H412		   
606-094-00-5N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]
benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one		417-460-7-Aquatic Chronic 4H413-H413   
606-095-00-0(R,S)-2-azabicyclo[2.2.1] hept-5-en-3-one421-830-349805-30-3Acute Tox. 4 *
Skin Sens. 1		H302
H317		GHS07
Wng		H302
H317		   
606-096-00-63-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-
(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4
H-1-benzopyran-4-one		424-170-4130603-71-3Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
606-097-00-12,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone424-210-023911-85-5Aquatic Chronic 4H413-H413   
606-098-00-71-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione431-220-9158574-65-3Aquatic Chronic 4H413-H413   
606-099-00-25-methoxy-4'-(trifluoromethyl)valerophenone425-000-161718-80-7Aquatic Chronic 2H411GHS09H411   
606-100-00-62-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one425-150-894723-86-1Repr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3		H360F***
H302
H317
H412		GHS08
GHS07
Dgr		H360F***
H302
H317
H412		   
606-101-00-1reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-
9,10-anthracenedione;
1,5-bis[3-[(2-ethylhexyl) oxy]propyl]amino-9,10-anthracenedione;
1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;
1-[3-[(2-ethylhexyl) oxy]propyl]amino-5-[(3-methoxypropyl)amino]-
9,10-anthracenedione;
1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione		426-050-7165038-51-7Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
606-102-00-74-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone431-490-879876-59-8Aquatic Chronic 2H411GHS09H411   
606-103-00-21-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone426-460-6-Skin Sens. 1H317GHS07
Wng		H317   
606-104-00-81-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone426-830-778531-59-6Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
606-105-00-33,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione431-500-0226065-73-2Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
606-106-00-91-(4-(trans-4-butylcyclohexyl)phenyl)ethanone427-320-783626-30-6Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
606-107-00-48-azaspiro[4.5]decane-7,9-dione427-770-41075-89-4Acute Tox. 3 *
Aquatic Chronic 2		H301
H411		GHS06
GHS09
Dgr		H301
H411		   
606-108-00-X1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone436-710-6756-13-8Aquatic Chronic 3H412-H412   
606-109-00-52-(4-methyl-3-pentenyl)anthraquinone428-320-171308-16-2Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 4		H302
H317
H314		GHS07
Wng		H302
H317
H314		   
606-110-00-05-ethoxy-5H-furan-2-one428-330-42833-30-9Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1		H314
H312
H302
H373**
H317		GHS05
GHS08
GHS07
Dgr		H314
H312
H302
H373**
H317		   
606-111-00-65-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one428-410-967014-36-2Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2		H302
H317
H411		GHS07
GHS09
Wng		H302
H317
H411		   
606-112-00-1(4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-
6H-benzofuro[3a,3,2-ef] [2]benzazepin-6-one		428-690-21668-86-6Acute Tox. 4 *
Eye Irrit. 2
Aquatic Chronic 3		H302
H319
H412		GHS07
Wng		H302
H319
H412		   
606-113-00-71-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-
2-(4-methylphenylsulfonyl)propan-1-one		429-040-0272460-97-6Eye Dam. 1
Aquatic Chronic 4		H318
H314		GHS05
Dgr		H318
H314		   
606-114-00-24,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone429-150-967887-47-2Aquatic Chronic 4H413-H413   
606-115-00-8profoxydim (ISO);
2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]
butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one		-139001-49-3Carc. 2
Repr. 2
Skin Sens. 1		H351
H361d
H317		GHS08
GHS07
Wng		H351
H361d
H317		   
606-116-00-3tepraloxydim (ISO);
(RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-
5-perhydropyran-4-ylcyclohex-2-en-1-one		-149979-41-9Carc. 2
Repr. 2		H351
H361fd		GHS08
Wng		H351
H361fd		   
606-117-00-92,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one429-460-47078-98-0Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
606-118-00-4N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine429-640-252870-46-9Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H319
H400
H410		GHS07
GHS09
Wng		H319
H410		   
606-119-00-X(E)-3-methyl-5-cyclopentadecen-1-one429-900-5-Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
606-120-00-52,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one430-170-5114625-74-0Acute Tox. 4 *
Aquatic Chronic 3		H302
H412		GHS07
Wng		H302
H412		   
606-121-00-0(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro
-1'-(cyclohex-2'-en-4'-one)		430-460-1133636-82-5Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H314
H317
H400
H410		GHS05
GHS07
GHS09
Dgr		H314
H317
H410		   
606-122-00-63-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one430-820-8114341-88-7Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H373**
H315
H318
H317
H400
H410		GHS05
GHS08
GHS07
GHS09
Dgr		H302
H373**
H315
H318
H317
H410		   
606-123-00-14-hexadecyl-1-phenylpyrazolidin-3-one430-840-7-Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
606-124-00-71-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione421-080-7161462-35-7STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H373**
H400
H410		GHS08
GHS09
Wng		H373**
H410		   
606-125-00-21-benzylimidazolidine-2,4-dione421-340-16777-05-5Acute Tox. 4 *H302GHS07
Wng		H302   
606-126-00-81,4-bis(2,3-dihydroxypropylamino)anthraquinone421-470-799788-75-7Aquatic Chronic 2H411GHS09H411   
606-128-00-92,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione422-650-8148935-94-8Aquatic Chronic 4H413-H413   
606-129-00-45-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;
(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one		423-090-7156732-13-7Aquatic Chronic 4H413-H413   
606-130-00-X4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone423-860-256309-94-5Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
606-131-00-5cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione427-230-85571-36-8Repr. 1B
STOT RE 2 *
Aquatic Chronic 2		H360F***
H373**
H411		GHS08
GHS09
Dgr		H360F***
H373**
H411		   
606-132-00-0(6β)-6,19-epoxyandrost-4-ene-3,17-dione433-490-36563-83-3Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
606-134-00-1androsta-1,4,9(11)-triene-3,17-dione433-560-315375-21-0Repr. 2H361f***GHS08
Wng		H361f***   
606-135-00-7cyclohexadecanone438-930-82550-52-9Aquatic Chronic 4H413-H413   
606-136-00-2(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-
tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-
4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone		444-350-6133413-70-4Eye Irrit. 2
Aquatic Chronic 4		H319
H413		GHS07
Wng		H319
H413		   
606-137-00-8trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione444-750-0211387-26-7Aquatic Chronic 4H413-H413   
606-138-00-3(2-butyl-5-nitrobenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl] methanone444-800-1141645-23-0Flam. Liq. 3
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H226
H302
H373**
H315
H318
H317
H400
H410		GHS02
GHS05
GHS08
GHS07
GHS09
Dgr		H226
H302
H373**
H315
H318
H317
H410		 M=10 
606-139-00-9(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one444-830-5124379-29-9Aquatic Chronic 4H413-H413   
606-140-00-42-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one444-860-9474510-57-1STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H373**
H400
H410		GHS08
GHS09
Wng		H373**
H410		   
606-141-00-Xsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate418-410-7-Eye Irrit. 2H319GHS07
Wng		H319   
606-142-00-5reaction mass of: (1RS,2SR,7SR,8SR,E) 9 and
10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;
(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one		434-290-9-Acute Tox. 4 *
Aquatic Chronic 2		H302
H411		GHS07
GHS09
Wng		H302
H411		   
607-417-00-23-chloropropyl chloroformiate425-770-9628-11-5Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1		H331
H302
H373**
H315
H318
H317		GHS06
GHS05
GHS08
Dgr		H331
H302
H373**
H315
H318
H317		   
607-428-00-2tetrasodium ethylene diamine tetraacetate200-573-964-02-8Acute Tox. 4 *
Eye Dam. 1		H302
H318		GHS05
GHS07
Dgr		H302
H318		   
607-429-00-8edetic acid;
(EDTA)		200-449-460-00-4Eye Irrit. 2H319GHS07
Wng		H319   
607-471-00-71,6-bis((dibenzylthiocarbamoyl) disulfanyl)hexane429-280-6151900-44-6Aquatic Chronic 4H413-H413   
607-473-00-8pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid426-590-3187412-41-5Skin Sens. 1H317GHS07
Wng		H317   
607-477-00-X(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt426-740-8-Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2		H302
H318
H411		GHS05
GHS07
GHS09
Dgr		H302
H318
H411		   
607-481-00-1reaction mass of: trihexyl citrate;
dihexyloctyl citrate;
dioctylhexyl citrate;
dihexyldecyl citrate		430-290-8-Aquatic Chronic 4H413-H413   
607-482-00-7N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride430-360-884793-24-8Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
607-483-00-21,2-benzenedicarboxylic acid;
di-C6-8-branched alkylesters, C7-rich		276-158-171888-89-6Repr. 1BH360D***GHS08
Dgr		H360D***   
607-484-00-8ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-
1H-isoindol-5-ylazo)phenyl]ethylamino}propionate		430-480-0221452-67-1Aquatic Chronic 4H413-H413   
607-485-00-3(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-
(4-fluorophenyl)-1-piperidinecarboxylate		430-510-2-Aquatic Chronic 4H413-H413   
607-486-00-9potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino) -1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'-disulfonate402-110-8110081-40-8Aquatic Chronic 3H412-H412   
607-491-00-6reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-
3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2);
triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol]
and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)		427-140-9-Carc. 2H351GHS08
Wng		H351   
607-504-00-5diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-
dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate		422-670-7-Repr. 1A
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H361f
H301
H373**
H400
H410		GHS06
GHS08
GHS09
Dgr		H361f
H301
H373**
H410		   
607-509-00-22-phenoxyethyl 4-aminobenzoate430-880-588938-23-2Aquatic Chronic 2H411GHS09H411   
607-510-00-8(2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]
heptane-2-carboxylic acid 4,4-dioxide		427-200-476646-91-8Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1		H302
H315
H318
H317		GHS05
GHS07
Dgr		H302
H315
H318
H317		   
607-511-00-3reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-
3-oxopropyl)amino]-4-oxobutyric acid;
4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-
4-oxobutyric acid		423-750-4-Eye Irrit. 2
Aquatic Chronic 2		H319
H411		GHS07
GHS09
Wng		H319
H411		   
607-514-00-Xpotassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate427-240-2134841-35-3Skin Sens. 1H317GHS07
Wng		H317   
607-518-00-13-oxoandrost-4-ene-17-β-carboxylic acid414-990-0302-97-6Repr. 1A
Aquatic Chronic 4		H361f
H413		GHS08
Dgr		H361f
H413		   
607-519-00-7poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl) cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]427-280-0176429-27-9STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H335
H315
H318
H400
H410		GHS05
GHS07
GHS09
Dgr		H335
H315
H318
H410		   
607-520-00-2reaction mass of:
sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate;
disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate		427-740-0-Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
607-521-00-8tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate429-270-1136210-30-5Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
607-522-00-3sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate429-720-7184246-86-4Aquatic Chronic 3H412-H412   
607-523-00-9reaction mass of
mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3- sulfonatoanilino)-6-
[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]- 6-13-dichlorobenzo
[1,2-B:4,5-B']di[1,4] benzoxazine-4,11-disulfonate;
mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis (4-amino-3-sulfonatoanilino)-
1,3,5-triazin-2-ylamino]- 6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]
benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6- [methyl-(2-sulfonatoethyl)amino]-
1,3,5-triazin-2,4-diyldiimino]bis[benzo [1,2-B:4,5-B']di[1,4] benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-
[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo [1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate;
mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3' [(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-
1,3,5-triazin-2,4-diyldiimino] bis[benzo[1,2-B:4,5-B']di[1,4] benzoxazine-4,11-disulfonate		430-200-7-Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
607-524-00-4tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters430-310-5-Aquatic Chronic 4H413 H413   
607-525-00-X(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid431-520-164485-90-1Flam. Sol. 1****
Carc. 2
Aquatic Chronic 3		H228
H351
H412		GHS02
GHS08
Dgr		H228
H351
H412		   
607-528-00-6(S)-3-methyl-2-(2-oxotetrahydropyrimidine -1-yl)butyric acid430-900-2192725-50-1Eye Dam. 1H318GHS05
Dgr		H318   
607-529-00-1benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate426-070-667299-45-0Aquatic Chronic 3H412-H412   
607-530-00-7reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate406-040-9125643-61-0Aquatic Chronic 4H413-H413   
607-531-00-2methyl 3-amino-4,6-dibromo-2-methyl-benzoate425-190-6119916-05-1STOT RE 2 *
Aquatic Chronic 2		H373**
H411		GHS08
GHS09
Wng		H373**
H411		   
607-532-00-8(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-
cyclopentanecarboxylic acid, cyclohexylamine salt		425-510-4167944-94-7Aquatic Chronic 3H412-H412   
607-533-00-3pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-
(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]- 13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate		414-910-4-Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
607-534-00-9ethyl 2-(3-benzoylphenyl)propanoate414-920-960658-04-0Acute Tox. 3 *
STOT RE 1
Skin Sens. 1
Aquatic Chronic 2		H301
H372**
H317
H411		GHS06
GHS08
GHS09
Dgr		H301
H372**
H317
H411		   
607-535-00-4potassium 4-iodo-2-sulfonato-benzoic acid426-620-5-Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
607-536-00-X(2,6-xylyloxy) acetic acid430-910-713335-71-2Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3		H302
H318
H412		GHS05
GHS07
Dgr		H302
H318
H412		   
607-537-00-5isopropylammonium 2-(3-benzoylphenyl)propionate417-970-1-Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 1
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H301
H312
H372**
H318
H400
H410		GHS06
GHS05
GHS08
GHS09
Dgr		H301
H312
H372**
H318
H410		   
607-539-00-6propyl((4-(5-oxo-3-propylisoxazolidin -4-ylidenmethin)phenyl)
propoxycarbonylmethyleneamino) acetate		431-000-2198705-81-6Aquatic Chronic 4H413-H413   
607-540-00-11-(mercaptomethyl)cyclopropylacetic acid420-240-3162515-68-6Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2		H314
H312
H302
H317
H411		GHS05
GHS07
GHS09
Dgr		H314
H312
H302
H317
H411		   
607-541-00-7[(1-methyl-1,2-ethanediyl) bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)421-940-128698-31-9Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H400
H410		GHS05
GHS09
Dgr		H318
H410		   
607-542-00-2methyl 2-(4-butanesulfonamidophenoxy) tetradecanoate422-110-1-Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
607-543-00-8poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-
(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-
2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]		427-480-8176429-22-4STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H335
H315
H318
H400
H410		GHS05
GHS07
GHS09
Dgr		H335
H315
H318
H410		   
607-544-00-3ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-
1-yl)-4-oxo-quinoline-3-carboxylate		427-490-2158585-86-5Aquatic Chronic 3H412-H412   
607-545-00-91,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate424-070-094346-09-5Skin Irrit. 2
Aquatic Chronic 2		H315
H411		GHS07
GHS09
Wng		H315
H411		   
607-546-00-4reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-
nitrophenylazo)phenyl] methoxycarbonylmethylamino} acetate;
methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]
ethoxycarbonylmethylamino}acetate		424-290-7188070-47-5Skin Sens. 1H317GHS07
Wng		H317   
607-547-00-X18-methylnonadecyl 2,2 -dimethylpropanoate424-370-1125496-22-2Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic		H315
H317
H413		GHS07
Wng		H315
H317
H413		   
607-548-00-51-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate431-010-7154486-26-7Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2		H302
H318
H411		GHS05
GHS07
GHS09
Dgr		H302
H318
H411		   
607-549-00-0methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate424-430-7125778-19-0Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
607-550-00-62-amino-4-bromo-5-chlorobenzoic acid424-700-4-Eye Dam. 1
Aquatic Chronic 3		H318
H410		GHS05
Dgr		H318
H410		   
607-551-00-1tetrabutylammonium 2-amino-6-iodopurinate424-710-9156126-48-6Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2		H312
H302
H373**
H315
H318
H317
H411		GHS05
GHS08
GHS07
GHS09
Dgr		H312
H302
H373**
H315
H318
H317
H411		   
607-552-00-7hexadecyl 3-amino-4-isopropoxybenzoate424-830-1-Aquatic Chronic 4H413-H413   
607-553-00-27-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8)
-amino-8 (or 5)-[[4-[[4-[[4-amino-6 (or 7)-sulfo-1-naphthyl]azo]phenyl]
amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and
4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt		424-850-0-Eye Dam. 1H318GHS05
Dgr		H318   
607-554-00-82,4-diamino-5-[4-[(2-sulfoxyl ethyl) sulfonyl]phenylazo]benzenesulfonic acid424-870-127624-67-5Expl. 1.1
Eye Dam. 1
Aquatic Chronic 3		H201
H318
H412		GHS01
GHS05
Dgr		H201
H318
H412		   
607-555-00-31,1,3,3-tetramethylbutylperoxypivalate424-980-822288-41-1Flam. Liq. 2
Org. Perox. D
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2		H225
H242
H315
H317
H411		GHS02
GHS07
GHS09
Dgr		H225
H242
H315
H317
H411		   
607-556-00-92-acetoxymethylene-4-acetylphenylacetate425-160-224085-06-1Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H373**
H318
H317
H400
H410		GHS05 GHS08 GHS07 GHS09 DgrH302
H373**
H318
H317
H410		   
607-557-00-4salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and
[R-[R*R*]]-2,3-dihydroxybutanedioic acid		425-210-3169939-84-8Skin Sens. 1H317GHS07
Wng		H317   
607-558-00-X2S-isopropyl-5R-methyl-1R-cyclohexyl (2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-
[1,3]-oxathiolane-2-carboxylate		425-250-1147027-10-9Aquatic Chronic 2H411GHS09H411   
607-559-00-5coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-
4-hydroxybenzenepropanoic acid		425-400-6179986-09-5Aquatic Chronic 4H413-H413   
607-560-00-0(R,S)-2-butyloctanedioic acid431-210-450905-10-7Eye Dam. 1H318GHS05
Dgr		H318   
607-561-00-6sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl) ethylene)
ureido)-5-nitrobenzenesulfonate		425-460-3-Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
607-562-00-1reaction mass of: (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;
(2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate		425-530-398769-75-6Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2		H302
H318
H411		GHS05
GHS07
GHS09
Dgr		H302
H318
H411		   
607-563-00-75,7-dichloro-4-hydroxyquinoline-3-carboxylic acid431-250-2171850-30-9Aquatic Chronic 2H411GHS09H411   
607-564-00-21,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate425-730-051178-75-7Skin Sens. 1H317GHS07
Wng		H317   
607-565-00-83-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate425-820-188150-42-9Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H301
H373**
H318
H400
H410		GHS06
GHS05
GHS08
GHS09
Dgr		H301
H373**
H318
H410		   
607-566-00-3reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate;
bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate		426-140-6-Aquatic Chronic 4H413-H413   
607-567-00-9potassium 3-iodo-6-methylbenzenesulfonate426-300-5-Eye Dam. 1H318GHS05
Dgr		H318   
607-568-00-4potassium 2-chloro-3-(benzyloxy)propionate426-350-8138666-92-9Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1		H302
H373**
H318
H317		GHS05
GHS08
GHS07
Dgr		H302
H373**
H318
H317		   
607-569-00-Xreaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate;
sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate		426-470-0-Skin Sens. 1H317GHS07
Wng		H317   
607-570-00-5sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]
thio]methyl]-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate monohydrate		426-520-171420-85-4Skin Sens. 1H317GHS07
Wng		H317   
607-571-00-02-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate431-400-757374-49-9Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
607-572-00-6diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate426-790-0162208-27-7Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H312
H302
H373**
H317
H400
H410		GHS08
GHS07
GHS09
Wng		H312
H302
H373**
H317
H410		   
607-573-00-1reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-
3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate;
disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-
(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate		426-840-1-Eye Dam. 1H318GHS05
Dgr		H318   
607-574-00-7[1R-(1-α,2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl] butanedioate426-890-477341-67-4Eye Dam. 1H318GHS05
Dgr		H318   
607-575-00-24-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-
ylidene]penta-1,3-dienyl)- 1,2,3,4-tetrahydro-6-hydroxy-2,4-
dioxopyrimidin-1-yl)benzoic acid-triethylamine salt		426-900-7-STOT SE 3
Aquatic Chronic 3		H335
H412		GHS07
Wng		H335
H412		   
607-576-00-8branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate427-030-0-Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
607-577-00-3(2R*,3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-
(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate		427-100-0-Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H302
H318
H317
H412		GHS05
GHS07
Dgr		H302
H318
H317
H412		   
607-578-00-9ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-
isopropyl-5-oxo-1H-pyrazole-3-carboxylate		427-110-5-Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 4		H302
H373**
H413		GHS08
GHS07
Wng		H302
H373**
H413		   
607-579-00-4diethyl[(p-ethoxyanilino)methylene]malonate431-430-0103976-28-9Acute Tox. 4 *
Aquatic Chronic 2		H302
H411		GHS07
GHS09
Wng		H302
H411		   
607-580-00-Xethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-
1,8-naphthyridine-3-carboxylate		422-360-1100491-29-0Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
607-581-00-5ethyl 2-ethoxy-4-carboxymethylbenzoate427-630-299469-99-5Eye Dam. 1H318GHS05
Dgr		H318   
607-582-00-0reaction mass of:
tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)- 1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;
tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)- 1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate		427-650-1-Aquatic Chronic 3H412-H412   
607-583-00-64-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid427-680-5188907-52-0Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H318
H317
H412		GHS05
GHS07
Dgr		H318
H317
H412		   
607-584-00-1trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)
phenylamino]- 1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate		427-710-7215612-56-9Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H318
H317
H412		GHS05
GHS07
Dgr		H318
H317
H412		   
607-585-00-7strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate427-930-3-Skin Sens. 1H317GHS07
Wng		H317   
607-586-00-2dodecyl 3-amino-4-chlorobenzoate428-020-96195-20-6Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
607-587-00-8ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-
1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate		428-030-367914-69-6Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H302
H373**
H400
H410		GHS08
GHS07
GHS09
Wng		H302
H373**
H410		   
607-588-00-3reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate;
bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate		428-050-2-Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
607-589-00-9tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate428-070-191788-83-9STOT RE 1
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1		H372**
H302
H400
H410		GHS08
GHS07
GHS09
Dgr		H372**
H302
H410		   
607-590-00-4hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-
3-oxovaleramido]-4-isopropoxybenzoate		428-140-1210706-50-6Aquatic Chronic 4H413-H413   
607-591-00-Xreaction mass of:
trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-
3-(4-(2-sulfooxyethanesulfonyl) phenylazo)naphthalene-2,7-disulfonate;
disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl- 1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate		428-400-4-Eye Dam.H318GHS05
Dgr		H318   
607-592-00-5di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate428-870-0-Aquatic Chronic 4H413-H413   
607-593-00-04-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate429-000-2159235-16-2Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
607-594-00-6ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate429-020-1204254-96-6STOT RE 2 *
Skin Sens. 1		H373**
H317		GHS08
GHS07
Wng		H373**
H317		   
607-595-00-1N-amidino-N-methylglycine-2-oxopropionate429-120-5208535-04-0Eye Dam. 1H318GHS05
Dgr		H318   
607-596-00-7ethyl 2-(4-phenoxyphenyl)lactate429-220-9132584-17-9Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
607-597-00-2tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-
1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate		429-230-3-Eye Dam. 1H318GHS05
Dgr		H318   
607-598-00-8trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro- 1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate429-240-8212652-59-0Eye Dam. 1H318GHS05
Dgr		H318   
607-599-00-31,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate431-610-968860-54-8Org. Perox. D
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H242
H317
H400
H410		GHS02
GHS07
GHS09
Dgr		H242
H317
H410		   
607-600-00-7(1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate431-700-8-Aquatic Chronic 2H411GHS09H411   
607-601-00-21,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate429-370-5220410-74-2Acute Tox. 4 *H302GHS07
Wng		H302   
607-602-00-8ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate429-680-0122665-86-5Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
607-603-00-3lithium sodium 4,4',4''-(nitrilotris(ethane-2,1-diylimino
(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-
(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate		429-730-1193562-37-7Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
607-604-00-9guanidinium benzoate429-820-026739-54-8Acute Tox. 4 *H302GHS07
Wng		H302   
607-605-00-4methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate429-890-2144550-06-1Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
607-606-00-X(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid430-100-386978-24-7Acute Tox. 4 *H302GHS07
Wng		H302   
607-607-00-5reaction mass of: calcium bis(C10-14 branched alkyl salicylate);
calcium bis(C18-30-alkyl salicylate);
calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate;
calcium bis (C10-14 branched alkyl phenolate);
calcium bis (C18-30-alkyl phenolate);
calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate;
C10-14 branched alkyl phenol;
C18-30-alkyl phenol		430-180-1-Skin Irrit. 2
Aquatic Chronic 2		H315
H411		GHS07
GHS09
Wng		H315
H411		   
607-608-00-0pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-
5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)- 1,3-pentadienyl}-3-
methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate		430-210-1-Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
607-609-00-6ethyl (3R)-4-cyano-3-hydroxybutanoate430-220-6141942-85-0Eye Irrit. 2H319GHS07
Wng		H319   
607-610-00-1trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)
phenylazo)naphthalene-2-sulfonate		430-280-3-Skin Sens. 1H317GHS07
Wng		H317   
607-611-00-7methyl 3-amino-2,2,3-trimethylbutyrate431-720-790886-53-6Skin Corr. 1B
Acute Tox. 4 *
Aquatic Chronic 3		H314
H302
H412		GHS05
GHS07
Dgr		H314
H302
H412		   
607-612-00-2reaction mass of:
3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid;
ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate		432-190-1182176-52-9Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1		H302
H373**
H318		GHS05
GHS08
GHS07
Dgr		H302
H373**
H318		   
607-613-00-8reaction mass of: succinic acid;
monopersuccinic acid;
dipersuccinic acid;
monomethyl ester of succinic acid;
monomethyl ester of persuccinic acid;
dimethyl succinate;
glutaric acid;
monoperglutaric acid;
diperglutaric acid;
monomethyl ester of glutaric acid;
monomethyl ester of perglutaric acid;
dimethyl glutarate;
adipic acid;
monoperadipic acid;
diperadipic acid;
monomethyl ester of adipic acid;
monomethyl ester of peradipic acid;
dimethyl adipate;
hydrogen peroxide;
methanol;
water		432-790-1-Muta. 2
Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *		H341
H314
H332
H312
H302		GHS05
GHS08
GHS07
Dgr		H341
H314
H332
H312
H302		   
607-614-00-32-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid426-480-563562-33-4Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
607-615-00-9reaction product of thioglycerol and mercaptoacetic acid consisting mainly of
3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance		431-120-5-Acute Tox. 3 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1		H331
H302
H319
H317		GHS06
Dgr		H331
H302
H319
H317		   
607-616-00-42,4-dichloro-5-fluorobenzoylchloride428-390-186393-34-2STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H335
H315
H318
H317
H412		GHS05
GHS07
Dgr		H335
H315
H318
H317
H412		   
607-617-00-Xbis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate430-700-510138-36-0Skin Sens. 1H317GHS07
Wng		H317   
607-618-00-5menadione sodium bisulfite;
2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt		204-987-0130-37-0Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H319
H315
H400
H410		GHS07
GHS09
Wng		H319
H315
H410		   
607-619-00-0menadione nicotinamide bisulfite;
1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid,
compound with nicotin-3-amide (1:1)		277-543-773581-79-0Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H319
H315
H400
H410		GHS07
GHS09
Wng		H319
H315
H410		   
607-620-00-6trisodium nitrilotriacetate225-768-65064-31-3Carc. 2
Acute Tox. 4 *
Eye Irrit. 2		H351
H302
H319		GHS08
GHS07
Wng		H351
H302
H319		 Carc. 2; H351: C > 5 % 
607-621-00-1milbemectin (ISO);
[reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]		--Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1		H332
H302
H400
H410		GHS07
GHS09
Wng		H332
H302
H410		 M=100 
607-622-00-72-ethylhexyl-2-ethylhexanoate231-057-17425-14-1Repr. 2H361d***GHS08
Wng		H361d***   
607-623-00-2diisobutyl phthalate201-553-284-69-5Repr. 1BH360DfGHS08
Dgr		H360Df Repr. 1B; H360Df: C > 25 %
Repr. 2; H361f: 5 % < C < 25 %		 
607-624-00-8perfluorooctane sulfonic acid;
heptadecafluorooctane-1-sulfonic acid; [1]
potassium perfluorooctanesulfonate;
potassium heptadecafluorooctane-1-sulfonate; [2]
diethanolamine perfluorooctane sulfonate; [3]
ammonium perfluorooctane sulfonate;
ammonium heptadecafluorooctanesulfonate; [4]
lithium perfluorooctane sulfonate;
lithium heptadecafluorooctanesulfonate [5]		217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5]		1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5]		Carc. 2
Repr. 1B
STOT RE 1
Acute Tox. 4 *
Acute Tox. 4 *
Lact.
Aquatic Chronic 2		H351
H360D***
H372**
H332
H302
H362
H411		GHS08
GHS07
GHS09
Dgr		H351
H360D***
H372**
H332
H302
H362
H411		   
607-625-00-3clodinafop-propargyl (ISO)-105512-06-9Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H373**
H317
H400
H410		GHS08
GHS07
GHS09
Wng		H302
H373**
H317
H410		 Skin Sens. 1; H317: C > 0,001 %
M=1		 
607-626-00-9ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate401-290-5103112-35-2Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1		H350
H400
H410		GHS08
GHS09
Dgr		H350
H410		   
607-627-00-4[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate416-360-0162221-28-5Skin Sens. 1H317GHS07
Wng		H317   
607-628-00-X4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine419-240-6171054-89-0Eye Dam. 1H318GHS05
Dgr		H318   
607-629-00-5[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid419-270-1123599-82-6Eye Irrit. 2H319GHS07
Wng		H319   
607-630-00-0acrylic acid, 3-(trimethoxysilyl)propyl ester419-560-64369-14-6Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 3		H332
H314
H317
H412		GHS05
GHS07
Dgr		H332
H314
H317
H412		   
607-631-00-6reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;
(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate		442-300-8-Skin Sens. 1H317GHS07
Wng		H317   
607-632-00-1N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-
(2-methylpropyl-oxycarbonylamino)-naphthamide		420-210-1111244-14-5Aquatic Chronic 4H413-H413   
607-633-00-7trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-
4-hydroxy-3-[(E)- (4-methoxy-2-sulfonatophenyl)diazenyl]-
2,7-naphthalenedisulfonate		440-480-2341026-59-3Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
607-634-00-2(S)-(-)-2-acetoxypropionylchloride;
(1S)-2-chloro-1-methyl-2-oxoethyl acetate		420-610-436394-75-9Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1		H302
H314
H317		GHS05
GHS07
Dgr		H302
H314
H317		   
607-635-00-8trisodium N-(3-propionato)-l-aspartate422-090-4172737-80-3Eye Dam. 1H318GHS05
Dgr		H318   
607-636-00-31-bromo-2-methylpropyl propionate422-900-6158894-67-8Flam. Liq. 3
Carc. 2
Skin Corr. 1B
Skin Sens. 1		H226
H351
H314
H317		GHS02
GHS05
GHS08
GHS07
Dgr		H226
H351
H314
H317		   
607-637-00-9disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}
naphthalene-2-sulfonate		423-730-5250688-43-8Eye Dam. 1H318GHS05
Dgr		H318   
607-638-00-42-hydroxybenzoic acid 2-butyloctyl ester431-090-3190085-41-7Aquatic Chronic 4H413-H413   
607-639-00-X2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-
(1,1,3,3-tetramethylbutyl)phenyl acetate		431-770-1216698-07-6Aquatic Chronic 4H413-H413   
607-641-00-02-(formylamino)-3-thiophenecarboxylic acid;
2-formamido-3-thiophenecarboxylic acid		431-930-943028-69-9Acute Tox. 4 *
Skin Sens. 1		H302
H317		GHS07
Wng		H302
H317		   
607-642-00-63,6,9-trithiaundecamethylene-1,11-dimethacrylate432-210-7141631-22-3Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
607-643-00-1dimethyl (2S)-2-hydroxysuccinate432-310-0617-55-0Flam. Liq. 3
Eye Dam. 1
Skin Sens. 1		H226
H318
H317		GHS02
GHS05
GHS07
Dgr		H226
H318
H317		   
607-644-00-7methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate432-350-981752-87-6Skin Irrit. 2H315GHS07
Wng		H315   
607-645-00-2tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl) ethyl)amino)- 1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo) naphthalene-1,7-disulfonate432-550-6243858-01-7Eye Dam. 1H318GHS05
Dgr		H318   
607-646-00-8d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-
1,1-dimethylethylester;
tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate		432-960-5124655-09-0Acute Tox. 4 *H302GHS07
Wng		H302   
607-647-00-35-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane433-530-1143446-73-5Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1		H302
H317
H400		GHS07
GHS09
Wng		H302
H317
H400		   
607-649-00-4[3-(chlorocarbonyl)-2-methylphenyl]acetate433-690-0167678-46-8Skin Corr. 1A
Skin Sens. 1		H314
H317		GHS05
GHS07
Dgr		H314
H317		   
607-650-00-X2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate433-910-5145153-52-2Skin Sens. 1H317GHS07
Wng		H317   
607-651-00-5sodium 2-(nonanoyloxy)benzenesulfonate434-360-991125-43-8Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
607-652-00-0ethyl N2-dodecanoyl-l-argininate hydrochloride434-630-660372-77-2Eye Dam. 1
Aquatic Acute 1		H318
H400		GHS05
GHS09
Dgr		H318
H400		   
607-653-00-6tetrakis(bis(2-hydroxyethyl) methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-
sulfonatonaphthalen-2-ylazo)-5-methoxy- 2-sulfonatophenylazo)-7-
(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate		434-840-8225786-91-4Aquatic Chronic 2H411GHS09H411   
607-654-00-1(S)-3-hydroxy-γ-butyrolactone434-990-47331-52-4Skin Sens. 1H317GHS07
Wng		H317   
607-655-00-7ethyl 6,8-dichlorooctanoate435-080-11070-64-0Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
607-656-00-2sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-
1,3,5-triazin-2-yl]amino]-2- sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid		435-350-7141250-43-3Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
607-657-00-8pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-
(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-
2-ureidophenylazo)naphthalene-1,3,6-trisulfonate		436-920-8172399-10-9Eye Dam. 1H318GHS05
Dgr		H318   
607-658-00-33,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-
naphthalenyl)sulfonyl)-4,11- triphenodioxazinedisulfonic acid, lithium potassium sodium salt		440-770-9371921-63-0Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
607-659-00-9pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-
[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6- chloro
-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl]
sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid		442-030-0321912-47-4Eye Dam. 1H318GHS05
Dgr		H318   
607-660-00-42-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]
phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt		442-230-8321679-52-1Eye Dam. 1H318GHS05
Dgr		H318   
607-661-00-X1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate442-850-9114772-40-6Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
607-662-00-5methyl 2-(acetylamino)-3-chloropropionate442-860-387333-22-0Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
607-663-00-0bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate442-980-6127474-91-3Aquatic Chronic 4H413-H413   
607-664-00-6methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate443-120-2393509-79-0Eye Dam. 1
Aquatic Chronic 2		H318
H411		GHS05
GHS09
Dgr		H318
H411		   
607-665-00-1trans-methyl-2-ethyl-but-2-enoate443-150-6101226-85-1Flam. Liq. 3H226GHS02
Wng		H226   
607-666-00-7(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid443-560-588784-33-2Eye Irrit. 2H319GHS07
Wng		H319   
607-667-00-2chloro-1-ethylcyclohexyl carbonate444-950-899464-83-2Muta. 2
Skin Sens. 1		H341
H317		GHS08
GHS07
Wng		H341
H317		   
607-668-00-8trans-2-isopropyl-5-carboxy-1,3-dioxane445-770-242031-28-7Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
607-669-00-3methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro
[5.5]undec-3-yl)octadecanoate		445-990-9376588-17-9Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
607-670-00-9dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;
(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate		448-700-9500791-70-8STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H373**
H318
H317
H400
H410		GHS05
GHS08
GHS07
GHS09
Dgr		H373**
H318
H317
H410		 M=10 
607-671-00-4diethyl 1,4-cyclohexanedicarboxylate417-310-072903-27-6Aquatic Chronic 2H411GHS09H411   
607-672-00-Xreaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;
1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;
x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate		419-000-0-Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
607-673-00-51-ethyl-5,6,7,8-tetrahydroquinolinium tosylate419-570-0-Acute Tox. 4 *
Aquatic Chronic 3		H302
H412		GHS07
Wng		H302
H412		   
607-675-00-6reaction mass of: cis-9-octadecenedioic acid;
cis-9-cis-12-octadecadienedioic acid;
hexadecanedioic acid;
octadecanedioic acid		422-260-8-Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H400
H410		GHS05
GHS09
Dgr		H318
H410		   
607-676-00-1reaction mass of: 2-methylnonanedioic acid;
2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;
8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid		423-670-1-Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
607-677-00-72,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-
4-thiazolyl]methyl]amino]carbonyl}-l-valinate		424-660-8-STOT RE 2 *
Eye Dam. 1
Skin Sens. 1		H373**
H318
H317		GHS05
GHS08
GHS07
Dgr		H373**
H318
H317		   
607-678-00-2reaction mass of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;
ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate		427-090-8-Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
607-679-00-8reaction mass of:
3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-
6-oxo-3-pyridylazo}benzamido)phenylazo]- 1,2-dihydro-6-hydroxy-4-methyl-
2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);
3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-
6-oxo-3-pyridylazo}benzamido]phenylazo]- 1,2-dihydro-6-hydroxy-4-methyl-
2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);
3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl- 6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-
2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)		431-440-5-Eye Dam. 1
Aquatic Chronic 2		H318
H411		GHS05
GHS09
Dgr		H318
H411		   
607-680-00-3tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]
pyrimidin-5-yl]vinyl} (4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate		432-810-9-Aquatic Chronic 4H413-H413   
607-681-00-9reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;
9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;
dihexadecyl 9-nonyl-10-octylnonadecandioate;
1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;
dioctadecyl 9-nonyl-10-octylnonadecandioate		432-910-2-Aquatic Chronic 4H413-H413   
607-682-00-4complex reaction mass of Chinese gum rosin post reacted with acrylic acid434-230-1144413-22-9Aquatic Chronic 4H413-H413   
607-683-00-Xreaction mass of:
methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)		435-450-0-Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
607-684-00-5alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts435-660-2243662-67-1Skin Irrit. 2
Skin Sens. 1		H315
H317		GHS07
Wng		H315
H317		   
607-685-00-0ammonium 2-cocoyloxyethanesulfonate441-050-7-Skin Irrit. 2
Eye Dam. 1		H315
H318		GHS05
Dgr		H315
H318		   
607-686-00-66,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylene-bis
(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)- 6-methyl-
2-phenylene]di(naphthalene-1-sulfonate)		441-550-5-Self-react. C ****
Carc. 2		H242
H351		GHS02
GHS08
Dgr		H242
H351		   
607-687-00-1reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-
benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (7-20 %)		442-800-6-Skin Irrit. 2
Aquatic Chronic 2		H315
H411		GHS07
GHS09
Wng		H315
H411		   
607-688-00-7(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride444-320-2-Acute Tox. 4 *H302GHS07
Wng		H302   
607-689-00-2reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate
("para-isomer" including cis- and trans- isomers);
methyl 1,3-dimethylcyclohexanecarboxylate ("meta-isomer" including cis- and trans-isomers)		444-920-4-Aquatic Chronic 3H412-H412   
607-690-00-8dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S,S'-bi (L-homocysteinyl) diimino]dihexanoate432-860-1255387-46-3Skin Sens. 1H317GHS07
Wng		H317   
607-691-00-3magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear448-690-6-Aquatic Chronic 4H413-H413   
607-692-00-9zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear446-470-4-Aquatic Chronic 4H413-H413   
607-693-00-4hexyl 2-(1-(diethylaminohydroxyphenyl) methanoyl)benzoate443-860-6302776-68-7Aquatic Chronic 4H413-H413   
607-694-00-Xethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate443-870-0163520-33-0Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H317
H400
H410		GHS07
GHS09
Wng		H302
H317
H410		   
608-020-00-7diphenoxymethylenecyanamide427-300-879463-77-7Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
608-032-00-2acetamiprid (ISO);
(E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine		-135410-20-7Acute Tox. 4 *
Aquatic Chronic 3		H302
H412		GHS07
Wng		H302
H412		   
608-042-00-7(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide421-810-4194602-27-2Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2		H302
H318
H317
H411		GHS05
GHS07
GHS09
Dgr		H302
H318
H317
H411		   
608-044-00-82-cyclohexylidene-2-phenylacetonitrile423-740-110461-98-0Acute Tox. 4 *
Aquatic Chronic 2		H302
H411		GHS07
GHS09
Wng		H302
H411		   
608-046-00-95-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-
1,4-dimethyl-2-oxo-pyridine-3-carbonitrile		425-310-777889-90-8Aquatic Chronic 4H413-H413   
608-047-00-42-piperidin-1-yl-benzonitrile427-330-172752-52-4Aquatic Chronic 2H411GHS09H411   
608-048-00-X1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile427-450-4152630-47-2Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 2		H302
H373**
H317
H411		GHS08
GHS07
GHS09
Wng		H302
H373**
H317
H411		   
608-049-00-52-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-
1,5-dihydropyrrol-2-ylidene)propandinitrile		429-180-2157362-53-3Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
608-050-00-0reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)
ethylamino)-4-methyl-6-phenylaminonicotinonitrile;
5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-
4-methyl-2-phenylaminonicotinonitrile		429-760-5-Aquatic Chronic 4H413-H413   
608-051-00-6(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-
3-(hydroxymethyl)benzonitrile		430-760-2219861-18-4Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2		H302
H317
H411		GHS07
GHS09
Wng		H302
H317
H411		   
608-052-00-1(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-
3-(hydroxymethyl)benzonitrile		430-770-7128173-52-4Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2		H302
H317
H411		GHS07
GHS09
Wng		H302
H317
H411		   
608-053-00-7(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-
3-(hydroxymethyl)benzonitrile		430-780-1103146-25-4Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2		H302
H317
H411		GHS07
GHS09
Wng		H302
H317
H411		   
608-054-00-2(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-
3-(hydroxymethyl)benzonitrile hemisulfate		430-790-6-Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2		H302
H318
H317
H411		GHS05
GHS07
GHS09
Dgr		H302
H318
H317
H411		   
608-055-00-8fipronil (ISO);
5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-
[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile		-120068-37-3Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1		H331
H311
H301
H372**
H400
H410		GHS06
GHS08
GHS09
Dgr		H331
H311
H301
H372**
H410		 M=10 
608-056-00-3N-methyl-N-cyanomethylmorpholiniummethylsulfate429-340-1-Acute Tox. 4 *
Eye Dam. 1		H302
H318		GHS05
GHS07
Dgr		H302
H318		   
608-057-00-94-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate431-200-1208538-34-5Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1		H302
H318
H317		GHS05
GHS07
Dgr		H302
H318
H317		   
608-059-00-X5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile421-240-6120068-79-3Aquatic Chronic 2H411GHS09H411   
608-060-00-55-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile421-300-1138564-59-7Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
608-062-00-62-fluoro-4-hydroxybenzonitrile422-810-782380-18-5Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2		H302
H318
H411		GHS05
GHS07
GHS09
Dgr		H302
H318
H411		   
608-063-00-1(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile441-070-661826-76-4Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H301
H318
H317
H400
H410		GHS06
GHS05
GHS09
Dgr		H301
H318
H317
H410		   
608-064-00-7cyanomethyltrimethylammoniummethylsulfate433-720-2-Aquatic Chronic 3H412-H412   
609-069-00-7musk ketone;
3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;
4'-tert-butyl-2',6'-dimethyl-3',5'-dinitroacetophenone		201-328-981-14-1Carc. 2
Aquatic Acute 1
Aquatic Chronic 1		H351
H400
H410		GHS08
GHS09
Wng		H351
H410		   
609-072-00-34-mesyl-2-nitrotoluene430-550-01671-49-4Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3		H361f***
H302
H317
H412		GHS08
GHS07
Dgr		H361f***
H302
H317
H412		   
609-073-00-9lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-
(2-ureidophenylazo)]naphthalene- 1,3,6-trisulfonato]}-N'-(2-aminoethyl) piperazine		427-850-9-Skin Sens. 1H317GHS07
Wng		H317   
611-050-00-3reaction mass of:
pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-
sulfonato-2-naphthyl)azo]-7-sulfonato-1- naphthyl]azo]phenyl]amino]-
3-sulfonatophenyl]azo]-6-sulfonato-1- naphthyl]azo]-4-hydroxynaphthalen-
2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-
naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-
sulfonato-phenylazo]-6-sulfonato-
naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-
ylazo)-7 -sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-
6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-
naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6- sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;
tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-
naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6- sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate		415-350-3-Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
611-102-00-5reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-
{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)- 3,6-disulfonato-2-
naphthylazo]phenylsulfonylamino} benzendiazoniumchlorid;
disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]
phenylsulfonylamino}benzen-diazoniumchlorid		424-500-7-Aquatic Chronic 3H412-H412   
611-139-00-7reaction product of: C.I. Leuco Sulfur Black 1 with
(3-chloro-2-hydroxypropyl)trimethylammonium chloride		424-510-1-Eye Dam. 1
Aquatic Chronic 2		H318
H411		GHS05
GHS09
Dgr		H318
H411		   
611-141-00-85-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-
ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt		414-410-6-Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
611-142-00-3product-by-process definition polyazodyestuff obtained by coupling
4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]
benzenediazonium with reaction mass of 4-carboxybenzenediazonium and
diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the
obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;
sodium chloride		425-740-5-Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
611-143-00-9reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)
benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-
sulfonatophenolatocuprate (II);
trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]
hydrazino-κ-N')- 6-(4,6-difluoropyrimidin-2-ylamino)- 4-sulfonatophenolatocuprate (II)		428-260-4-Eye Dam. 1H318GHS05
Dgr		H318   
611-144-00-4reaction mass of:
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl) phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;
7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-
[4-(2-sulfoxyethylsulfonyl)- 2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-
[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;
7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-
hydroxynaphthalene-2-sulfonic acid, Na/K salt		429-070-4214362-06-8Eye Dam. 1H318GHS05
Dgr		H318   
611-145-00-Xreaction mass of:
tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-
[4-(2-sulfoxyethylsulfonyl)phenylamino]- 1,3,5-triazine-2-ylamino}
naphthalene-2-sulfonate;
3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-
sulfoxyethylsulfonyl)phenylamino]- 1,3,5-triazine-2-ylamino}naphthalene-
2-sulfonic acid, sodium salt		429-440-5-Eye Dam. 1H318GHS05
Dgr		H318   
611-146-00-5reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-
(4-sulfonatophenylazo)phenylazo)-1- hydroxy-3-sulfonatonaphthalen-2-ylazo)- 2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-
phenylcarbamoylpropylazo)naphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3- ((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-
sulfonatonaphthalen-2-yl)azo)phenyl)amino)- 2-sulfonatophenyl)azo)-4-
hydroxynaphthalene-2-sulfonate;
pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)
azo)phenyl)azo)-3- ((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2- sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate;
hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3- ((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-
1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)- 2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate		430-070-1-Aquatic Chronic 2H411GHS09H411   
611-147-00-0sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-
(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-
2-sulfonatophenylazo)-4-hydroxynaphthalene-
2,7-disulfonate		430-090-0205764-96-1Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
611-148-00-6reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;
2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol;
3-(2,6-dichloro-4-nitrophenylazo)carbazol		429-590-1-Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
611-149-00-12-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-
methylphenyl)ethylamino) propionate		427-570-7193486-83-8Aquatic Chronic 2H411GHS09H411   
611-150-00-7tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-
naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate		440-460-3-Eye Irrit. 2
Aquatic Chronic 3		H319
H412		GHS07
Wng		H319
H412		   
611-151-00-2chrysoidine;
4-(phenylazo)benzene-1,3-diamine		207-803-7495-54-5Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H341
H302
H315
H400
H410		GHS08
GHS07
GHS09
Wng		H341
H302
H315
H410		   
611-152-00-8chrysoidine monohydrochloride;
4-phenylazophenylene-1,3-diamine monohydrochloride; [1]
chrysoidine monoacetate;
4-(phenylazo)benzene-1,3-diamine monoacetate; [2]
chrysoidine acetate;
4-(phenylazo)benzene-1,3-diamine acetate; [3]
chrysoidine-p-dodecylbenzenesulfonate;
dodecylbenzenesulfonic acid, compound with
4-(phenylazo)benzene-1,3-diamine (1:1); [4]
chrysoidine dihydrochloride;
4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5]
chrysoidine sulfate;
bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6]		208-545-8 [1]
278-290-5 [2]
279-116-0 [3]
264-409-8 [4]
281-549-5 [5]
282-432-1 [6]		532-82-1 [1]
75660-25-2 [2]
79234-33-6 [3]
63681-54-9 [4]
83968-67-6 [5]
84196-22-5 [6]		Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H341
H302
H315
H318
H400
H410		GHS05
GHS08
GHS07
GHS09
Dgr		H341
H302
H315
H318
H410		   
611-153-00-3chrysoidine C10-14-alkyl derivatives;
benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1]
chrysoidine compound with dibutylnaphthalene sulfonic acid;
dibutylnaphthalenesulfonic acid, compound with
4-(phenylazo)benzene-1,3-diamine (1:1) [2]		286-946-7 [1]
304-236-8 [2]		85407-90-5 [1]
94247-67-3 [2]		Muta. 2
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1		H341
H302
H315
H318		GHS05
GHS08
GHS07
Dgr		H341
H302
H315
H318		   
611-154-00-9trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo) naphthalene-2,7-disulfonate403-670-692408-46-3Aquatic Chronic 3H412-H412   
611-155-00-44,4'-oxybis(benzenesulfonylazide)431-850-47456-68-0Expl. 1.1****
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H201
H373**
H400
H410		GHS01
GHS08
GHS09
Dgr		H201
H373**
H410		   
611-156-00-Xtriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-
naphthylazo] -2,5-dimethoxyphenylazo]benzoate		432-270-4221354-37-6Repr. 2
STOT RE 2 *
Aquatic Chronic 2		H361f***
H373**
H411		GHS08
GHS09
Wng		H361f***
H373**
H411		   
611-157-00-5benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene) azo))
bis-, potassium sodium salt;
potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)
diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl] benzenesulfonate		432-590-4243869-48-9Eye Irrit. 2
Aquatic Chronic 3		H319
H412		GHS07
Wng		H319
H412		   
611-158-00-0reaction product of:
2,3,4,2',3',4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and
6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride		421-520-8-****
Aquatic Chronic 4		****
H413		********
H413		   
611-159-00-6disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)
phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate		421-880-6-Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
611-160-00-1reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-
oxo-naphthalene-1''-sulfonato)ethane;
1,1,1-tris(phenyl-4'-(6''-diazo-5'',6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane;
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with
6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-
3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with
6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-
3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)		422-760-6-****
Aquatic Chronic 4		****
H413		********
H413		   
611-161-00-7trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-
(4'-nitrobenzene)diolato-O,O,N][(Z) - 2,2-((phenylcarbamoylprop-1'-
enyl)azo)-5-sulfamoylbenzene) diolato-O,O,N]chromate(III)		423-100-1-Eye Dam. 1H318GHS05
Dgr		H318   
611-162-00-22,4-bis(((2-(dimethylammonio)ethyloxy) carbonyl)phen-2-
ylazo)benzene-1,3-diolbis(methanesulfonate)		429-600-4-Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2		H302
H318
H411		GHS05
GHS07
GHS09
Dgr		H302
H318
H411		   
611-163-00-82,4-bis(((2-(dimethylammonio)ethyloxy) carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate429-610-9-Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2		H302
H318
H411		GHS05
GHS07
GHS09
Dgr		H302
H318
H411		   
611-164-00-3reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile;
2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile);
2,2'-dimethyl-2,2'-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)		429-710-2-Self React D
Acute Tox. 4 *
Aquatic Chronic 2		H242
H302
H411		GHS02
GHS07
GHS09
Dgr		H242
H302
H411		   
611-165-00-9reaction mass of:
tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-
5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo) naphthalene-2,7-disulfonate;
tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-
sulfonatophenylazo)-5-hydroxy-3- (4-(2-sulfatoethylsulfonyl)phenylazo) naphthalene-2,7-disulfonate		431-830-5-Aquatic Chronic 3H412-H412   
611-166-00-4reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)
ethylsulfonyl] phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl] phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]
phenylazo}-6-[(E)-2- sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)
ethylsulfonyl] phenylazo}-3- [(E)-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate		432-100-9-Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
611-167-00-Xsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-
(4,8-disulfonato-2-naphthylazo)-5'- methyl-3-sulfonatonaphthalene-2-
azobenzene-1,2'-diolato]cuprate(II)		435-240-9-Aquatic Chronic 3H412-H412   
611-168-00-5reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-
8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]- 1,3,5-triazin-2-yl]amino]-
5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7- [(2-sulfophenyl)azo]-
1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-
naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid		435-440-6-Eye Dam. 1H318GHS05
Dgr		H318   
611-169-00-0sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate435-800-2-Aquatic Chronic 3H412-H412   
611-170-00-6reaction mass of: trisodium 2-((1-(2-hydroxy-?-O-5-
(2-sulfonatoethansulfonyl)phenylazo-?-N
disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-?-O-phenylazo-?-N2)-1-phenylmethyl)
azo-?-N1)-4-sulfonatobenzoate-?-O-(5-))cuprate(II)		435-880-9-Aquatic Chronic 3H412-H412   
611-171-00-1reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-
sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl- 1,3,5-triazin-2-ylamino)-
4-hydroxy-2,7-naphthalenedisulfonate;
trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-
(4-fluoro-6-morpholin-4-yl- 1,3,5-triazin-2-ylamino)-4-
hydroxy-2,7-naphthalenedisulfonate		436-890-6-Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
611-172-00-7reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)
phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)
azo)-2,5-diethoxyphenyl) azo)benzoate		438-310-7-Self-react. C****
Repr. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3		H242
H361f***
H302
H373**
H412		GHS02
GHS08
GHS07
Dgr		H242
H361f***
H302
H373**
H412		   
611-173-00-2reaction mass of:
3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-
triazin-2-ylamino}-2-sulfonatophenylazo)- 1,2-dihydro-6-hydroxy-4-methyl-2-oxo-
1-pyridyl]propanoic acid, trisodium salt;
3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-
2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy- 4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt		440-510-4-Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
611-174-00-8reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5- {4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-
3-sulfophenylamino]- 1,3,5-triazin-2-ylamino}- 4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-
[6-(4-(3-amino-5-hydroxy-2,7- disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-
1,3,5-triazin-2-ylamino}-
4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt		442-290-5457624-86-1Eye Dam. 1H318GHS05
Dgr		H318   
611-175-00-3reaction mass of:
trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-
1,3,5-triazin-2-ylamino}-4-hydroxy- 3-[4-(vinylsulfonyl)phenylazo]
naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-
1,3,5-triazin-2-ylamino}-
4-hydroxy-3- [4-(2-(sulfonatooxy)ethylsulfonyl) phenylazo]
naphthalene-2,7-disulfonate;
disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-
1,3,5-triazin-2-ylamino}-4-hydroxy-3- [(4-vinylsulfonyl)
phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)
ethylsulfonyl)anilino]-1,3,5-triazin-2-
ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl) phenylazo]-4-hydroxynaphthalene-2,7-disulfonate		444-050-5-Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
611-176-00-92,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-
oxo-1-naphthalenesulfonate		444-250-2-Self-react. C****
Aquatic Chronic 2		H242
H411		GHS02
GHS09
Dgr		H242
H411		   
611-177-00-4reaction mass of:
pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-
1,2'-diolato][6-anilino-5'-sulfamoyl-3- sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);
trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-
1,2'-diolato]cobaltate(III)		444-290-0508202-43-5Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H318
H317
H412		GHS05
GHS07
Dgr		H318
H317
H412		   
611-178-00-Xreaction mass of:
pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]
phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]
phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl] phenylazo}-6- [(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)
ethylsulfonyl] phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)
-2-sulfonato-4-(vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-
[(E)-2-sulfonato-4- (vinylsulfonyl)phenylazo] naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-
[-2-sulfonato-4- (2-hydroxyethylsulfonyl) phenylazo]naphthalene-2,7-disulfonate		445-280-9-Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H318
H317
H412		GHS05
GHS07
Dgr		H318
H317
H412		   
611-179-00-5reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]
phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]
azo]naphthalene-1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate		450-010-8-Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
611-180-00-0iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised
3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide,
diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts		417-850-7-Aquatic Chronic 2H411GHS09H411   
612-057-01-1piperazine;
[liquid]		203-808-3110-85-0Repr. 2
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1		H361fd
H314
H334
H317		GHS05
GHS08
Dgr		H361fd
H314
H334
H317		   
612-122-01-4hydroxylamine ... % [? 55 % in aqueous solution]232-259-27803-49-8Met. Corr. 1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1		H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400		GHS05
GHS08
GHS07
GHS09
Dgr		H290
H351
H312
H302
H373**
H335
H315
H318
H317
H400		  B
612-169-00-3bis(N-methyl-N-phenylhydrazine) sulfate423-170-1618-26-8Flam. Liq. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H225
H372**
H302
H318
H317
H400
H410		GHS02
GHS05
GHS08
GHS07
GHS09
Dgr		H225
H372**
H302
H318
H317
H410		   
612-203-00-7C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8:
< 3 %, chain = C8: 15 %-70 %, chain = C10: 30 %-85 %, chain > C10: < 3 %)		417-360-3-Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2		H312
H302
H315		GHS07
Wng		H312
H302
H315		   
612-208-00-4N-methylbenzene-1,2-diammonium hydrogen phosphate424-460-0-Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2		H302
H317
H411		GHS07
GHS09
Wng		H302
H317
H411		   
612-216-00-81-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt425-870-219450-38-5Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
612-219-00-4(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-
yloxy)propyl)trimethylammonium chloride		402-200-7-Aquatic Chronic 3H412-H412   
612-220-00-XN-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine431-060-1153719-38-1Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3		H302
H317
H412		GHS07
Wng		H302
H317
H412		   
612-221-00-52-amino-4-(trifluoromethyl)benzenethiol hydrochloride429-560-84274-38-8Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1		H314
H332
H312
H302
H373**
H317
H400		GHS05
GHS08
GHS07
GHS09
Dgr		H314
H332
H312
H302
H373**
H317
H400		   
612-222-00-0cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine425-080-8104860-26-6Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H312
H302
H373**
H318
H400
H410		GHS05
GHS08
GHS07
GHS09
Dgr		H312
H302
H373**
H318
H410		   
612-223-00-6N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine425-300-2186450-73-7Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
612-224-00-1N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine426-150-0121246-28-4Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
612-225-00-71,4,7,10-tetraazacyclododecane425-450-9294-90-6Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1		H314
H312
H302
H400
H410		GHS05
GHS07
GHS09
Dgr		H314
H312
H302
H410		   
612-226-00-23-(2'-phenoxyethoxy)propylamine427-870-86903-18-0Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3		H302
H315
H318
H412		GHS05
GHS07
Dgr		H302
H315
H318
H412		   
612-227-00-8benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride428-290-8120606-08-8Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H318
H400
H410		GHS05
GHS07
GHS09
Dgr		H302
H318
H410		   
612-228-00-3reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;
N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;
N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine		414-340-6-Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
STOT SE 2
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H226
H332
H312
H302
H371
H318
H317
H412		GHS02
GHS05
GHS08
GHS07
Dgr		H226
H332
H312
H302
H371
H318
H317
H412		   
612-229-00-9mepanipyrim;
4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine		-110235-47-7Carc. 2
Aquatic Acute 1
Aquatic Chronic 1		H351
H400
H410		GHS08
GHS09
Wng		H351
H410		   
612-230-00-4N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide431-530-4-Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H314
H317
H400
H410		GHS05
GHS07
GHS09
Dgr		H314
H317
H410		   
612-231-00-X3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-
N,N-dimethyl-1-propanaminium chloride		427-370-1164288-56-6Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H400
H410		GHS05
GHS09
Dgr		H318
H410		   
612-232-00-5reaction mass of: triisopropanolamine salt of 1-amino-4-
(3-propionamidoanilino)anthraquinone-2-sulfonic acid;
triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-
(2-hydroxyethylaminosulfonyl) anilino]anthraquinone-2-sulfonic acid		430-410-9186148-38-9Aquatic Chronic 3H412-H412   
612-237-00-2hydroxylammonium hydrogensulfate;
hydroxylamine sulfate (1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphosphate; [3]
hydroxylamine 4-methylbenzenesulfonate [4]		233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]		10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]		Expl. 1.1
Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1		H201
H351
H312
H302
H373**
H319
H315
H317
H400		HS01
GHS08
GHS07
GHS09
Dgr		H201
H351
H312
H302
H373**
H319
H315
H317
H400		  T
612-238-00-8(3-chloro-2-hydroxypropyl) trimethylammonium chloride ... %222-048-33327-22-8Carc. 2
Aquatic Chronic 3		H351
H412		GHS08
Wng		H351
H412		  B
612-239-00-3biphenyl-3,3',4,4'-tetrayltetraamine;
diaminobenzidine		202-110-691-95-2Carc. 1B
Muta. 2		H350
H341		GHS08
Dgr		H350
H341		   
612-240-00-9pyrimethanil (ISO);
N-(4,6-dimethylpyrimidin-2-yl) aniline		-53112-28-0Aquatic Chronic 2H411GHS09H411   
612-241-00-4piperazine hydrochloride; [1]
piperazine dihydrochloride; [2]
piperazine phosphate [3]		228-042-7 [1]
205-551-2 [2]
217-775-8 [3]		6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3]		Repr. 2
Eye Irrit. 2
Skin Irrit. 2
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3		H361fd
H319
H315
H334
H317
H412		GHS08
Dgr		H361fd
H319
H315
H334
H317
H412		   
612-242-00-Xcyprodinil (ISO);
4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine		-121552-61-2Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		 M=10 
612-243-00-5(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-
naphthalenamine 2-hydroxy-2-phenylacetate		420-560-379617-97-3Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H400
H410		GHS05
GHS09
Dgr		H318
H410		 M=10 
612-244-00-03-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride421-310-687691-88-1Repr. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H361f***
H302
H319
H317
H400
H410		GHS08
GHS07
GHS09
Wng		H361f***
H302
H319
H317
H410		   
612-245-00-62-ethylphenylhydrazine hydrochloride421-460-219398-06-2Carc. 2
STOT RE 1
Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H351
H372**
H302
H318
H317
H400
H410		GHS05
GHS08
GHS07
GHS09
Dgr		H351
H372**
H302
H318
H317
H410		 M=10 
612-246-00-1(2-chloroethyl)(3-hydroxypropyl)ammonium chloride429-740-640722-80-3Carc. 1B
Muta. 1B
STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3		H350
H340
H373**
H317
H412		GHS08
GHS07
Dgr		H350
H340
H373**
H317
H412		   
612-247-00-7N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-
nitrobenzenecarboximidamide		423-530-8152828-23-4STOT RE 1
Acute Tox. 4 *
Aquatic Chronic 3		H372**
H302
H412		GHS08
GHS07
Dgr		H372**
H302
H412		   
612-248-00-2reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)439-540-0-Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 4		H315
H317
H413		GHS07
Wng		H315
H317
H413		   
612-249-00-84-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride425-030-5159939-85-2Repr. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2		H361f***
H302
H314
H317
H411		GHS05
GHS08
GHS07
GHS09
Dgr		H361f***
H302
H314
H317
H411		   
612-250-00-3chloro-N,N-dimethylformiminium chloride425-970-63724-43-4Repr. 1B
Acute Tox. 4 *
Skin Corr. 1A		H360D***
H302
H314		GHS05
GHS08
GHS07
Dgr		H360D***
H302
H314		EUH014  
612-251-00-9cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride426-020-351229-78-8Flam. Sol. 2
Repr. 2
Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2		H228
H361d***
H302
H315
H317
H411		GHS02
GHS08
GHS07
GHS09
Wng		H228
H361d***
H302
H315
H317
H411		   
612-252-00-4imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine		428-040-8138261-41-3Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1		H302
H400
H410		GHS07
GHS09
Wng		H302
H410		   
612-253-00-X7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing < 0,5 % formamide (EC No 200-842-0)]		429-400-7199327-61-2Aquatic Chronic 3H412-H412   
612-253-01-77-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;
[containing > 0,5 % formamide (EC No 200-842-0)]		429-400-7199327-61-2Repr. 1B
Aquatic Chronic 3		H360D***
H412		GHS08
Dgr		H360D***
H412		   
612-254-00-5reaction products of diisopropanolamine with formaldehyde (1:4)432-440-8220444-73-5Carc. 2
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2		H351
H302
H314
H317
H411		GHS05
GHS08
GHS07
GHS09
Dgr		H351
H302
H314
H317
H411		   
612-255-00-01-(3-methoxypropyl)-4-piperidinamine431-950-8179474-79-4Acute Tox. 4 *
Acute Tox. 4 *
Skin Corr. 1B
Aquatic Chronic 3		H312
H302
H314
H412		GHS05
GHS07
Dgr		H312
H302
H314
H412		   
612-256-00-6benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate427-470-3137864-22-3Acute Tox. 4 *
Skin Sens. 1		H302
H317		GHS07
Wng		H302
H317		   
612-257-00-1tripropylammonium dihydrogenphosphate433-700-335687-90-2Acute Tox. 4 *H302GHS07
Wng		H302   
612-259-00-2N-ethyl-3-trimethoxysilyl-2-methyl-propanamine437-720-3227085-51-0Eye Dam. 1H318GHS05
Dgr		H318   
612-261-00-33,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline441-190-9121451-05-6Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H317
H400
H410		GHS07
GHS09
Wng		H302
H317
H410		 M=10 
612-265-00-5bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate444-360-0191617-13-7Aquatic Chronic 3H412-H412   
612-266-00-03-chloro-4-(3-fluorobenzyloxy)aniline445-590-4202197-26-0Muta. 2
Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H341
H302
H373**
H400
H410		GHS08
GHS07
GHS09
Wng		H341
H302
H373**
H410		   
612-267-00-6bis(hydrogenated tallow C16-18-alkyl)hydroxylamine418-370-0-Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
612-269-00-7reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;
1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;
reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-
octyl-N-(4-octylphenyl)aniline;
N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline		420-720-2-Aquatic Chronic 4H413-H413   
612-270-00-2(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride433-010-2-Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3		H302
H317
H412		GHS07
Wng		H302
H317
H412		   
612-271-00-8reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-
ylazo)phenyl)ethylamino)benzoate;
ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate		434-970-5160987-57-5Aquatic Chronic 4H413-H413   
612-272-00-3ammonium (?-6-2-(2-(1,2-dicarboxylatoethylamino) ethylamino)butane-
1,4-dioato(4-)) iron(3+) monohydrate		435-210-5-Aquatic Chronic 2H411GHS09H411   
612-273-00-9alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride435-650-8-Acute Tox. 4 *
Skin Corr. 1A
Aquatic Acute 1
Aquatic Chronic 1		H302
H314
H400
H410		GHS05
GHS07
GHS09
Dgr		H302
H314
H410		   
612-274-00-4(R,S)-1-[2-amino-1 (4-methoxyphenyl)ethyl]cyclohexanol acetate445-750-3-Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H302
H318
H317
H412		GHS05
GHS07
Dgr		H302
H318
H317
H412		   
612-275-00-Xfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil447-880-6206565-89-1Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H315
H318
H317
H400
H410		GHS05
GHS07
GHS09
Dgr		H315
H318
H317
H410		 M=10 
612-276-00-51-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-
anthracenesulfonic acid, disodium salt, reaction products with
2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl
hydrogen sulfate, sodium salts		451-430-4500717-36-2Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H318
H317
H412		GHS05
GHS07
Dgr		H318
H317
H412		   
612-277-00-0reaction mass of:
4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-
(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl) phenylamino]-1,3,5-triazin-2-
ylamino}-2-sulfonatophenylazo)naphthalene-
2,7-disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)
phenylamino]-1,3,5-triazin-2-ylamino} -2-sulfonatophenylazo)-3-
(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)
phenylazo)naphthalene-2,7-disulfonate potassium/sodium		451-440-9586372-44-3Eye Dam. 1H318GHS05
Dgr		H318   
612-278-00-6ethidium bromide;
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide		214-984-61239-45-8Muta. 2
Acute Tox. 2 *
Acute Tox. 4 *		H341
H330
H302		GHS06
GHS08
Dgr		H341
H330
H302		   
612-279-00-1(R,S)-2-amino-3,3-dimethylbutane amide447-860-7144177-62-8Repr. 2
STOT RE 2 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1		H361f***
H373**
H319
H315
H317		GHS08
GHS07
Wng		H361f***
H373**
H319
H315
H317		   
612-280-00-73-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine		205-057-7132-32-1Carc. 1BH350GHS08
Dgr		H350  H
613-116-01-4tolylfluanid (ISO);
dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 µm]		211-986-9731-27-1Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1		H319
H335
H315
H317
H400		GHS07
GHS09
Wng		H319
H335
H315
H317
H400		 M=10 
613-161-00-22,4-diamino-6-hydroxymethylpteridinehydrobromide430-620-076145-91-0STOT RE 2 *
Skin Sens. 1
Aquatic Chronic 3		H373**
H317
H412		GHS08
GHS07
Wng		H373**
H317
H412		   
613-162-00-8(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]
oct-2-en-3-yl)methyl)pyridinium iodide		423-260-0100988-63-4Muta. 2
Skin Sens. 1
Aquatic Chronic 2		H341
H317
H411		GHS08
GHS07
GHS09
Wng		H341
H317
H411		   
613-187-00-45-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-
3-methyl-2,4-dicarbonitrilethiophene		410-530-8-Skin Sens. 1H317GHS07
Wng		H317   
613-192-00-13-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane426-750-2151860-15-0Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
613-198-00-42-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine415-500-8145963-84-4Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3		H302
H373**
H412		GHS08
GHS07
Wng		H302
H373**
H412		   
613-229-00-11-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine411-930-5106917-31-1Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H315
H317
H400
H410		GHS07
GHS09
Wng		H315
H317
H410		   
613-231-00-22,6-diamino-3-((pyridine-3-yl) azo)pyridine421-430-928365-08-4Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2		H302
H373**
H411		GHS08
GHS07
GHS09
Wng		H302
H373**
H411		   
613-232-00-83-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide431-030-6163269-30-5Acute Tox. 3 *
STOT RE 2 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H331
H373**
H318
H400
H410		GHS06
GHS05
GHS08
GHS09
Dgr		H331
H373**
H318
H410		   
613-234-00-9imidazo[1,2-b]pyridazin hydrochloride431-510-518087-70-2Acute Tox. 4 *
Eye Irrit. 2		H302
H319		GHS07
Wng		H302
H319		   
613-235-00-42,3-dihydro-2,2-dimethyl-1H-perimidine424-060-66364-17-6Acute Tox. 4*
STOT RE 2 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H373**
H317
H400
H410		GHS08
GHS07
GHS09
Wng		H302
H373**
H317
H410		   
613-236-00-X2-chloro-3-trifluoromethylpyridine424-520-665753-47-1Acute Tox. 3 *
Acute Tox. 3 *
STOT RE 1
Skin Corr. 1B
Aquatic Chronic 3		H311
H301
H372**
H314
H412		GHS06
GHS05
GHS08
Dgr		H311
H301
H372**
H314
H412		   
613-237-00-56-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine424-950-4133949-92-5Aquatic Chronic 4H413-H413   
613-238-00-0sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl) amino]phenyl]sulfonyl]ethyl sulfate430-890-181992-66-7Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		   
613-239-00-62-[3-(methylamino)propyl]-1H-benzimidazole425-760-464137-52-6Eye Dam. 1
Aquatic Chronic 3		H318
H412		GHS05
Dgr		H318
H412		   
613-241-00-73-(2H-tetrazol-5-yl)pyridine426-810-83250-74-6Eye Dam. 1H318GHS05
Dgr		H318   
613-242-00-2reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-
triphenodioxazinedisulfonic acid
with 2-amino-1,4-benzenedisulfonic acid,
2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-
1,3,5-triazine, sodium salts		426-860-0191877-09-5Eye Dam. 1H318GHS05
Dgr		H318   
613-243-00-84,4'-(1,6-hexamethylenebis (formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)427-350-0182235-14-9Aquatic Chronic 2H411GHS09H411   
613-244-00-35,7-dichloro-4-hydroxyquinoline427-420-021873-52-9Aquatic Chronic 2H411GHS09H411   
613-245-00-92-fluoro-6-trifluoromethylpyridine428-100-394239-04-0Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Chronic 3		H226
H332
H302
H412		GHS02
GHS07
Wng		H226
H332
H302
H412		   
613-246-00-42-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine428-200-7103577-66-8Aquatic Chronic 3H412-H412   
613-247-00-X3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole428-910-7107786-36-7Aquatic Chronic 4H413-H413   
613-248-00-53,4-dimethyl-1H-pyrazole429-130-12820-37-3Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3		H302
H318
H412		GHS05
GHS07
Dgr		H302
H318
H412		   
613-249-00-01-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate429-300-3155601-30-2Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2		H318
H317
H411		GHS05
GHS07
GHS09
Dgr		H318
H317
H411		   
613-250-00-6reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;
methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;
2-isopropyl-N-hydroxyethyl 1,3-oxazolidine		429-990-6-Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H318
H317
H412		GHS05
GHS07
Dgr		H318
H317
H412		   
613-251-00-1(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl) ethenyl]-1H-indole430-560-5180637-89-2Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1		H302
H373**
H318
H317		GHS05
GHS08
GHS07
Dgr		H302
H373**
H318
H317		   
613-253-00-22,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;
reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13,
average degree of ethoxylation is 3,5)		430-580-4-Skin Irrit. 2
Aquatic Chronic 2		H315
H411		GHS07
GHS09
Wng		H315
H411		EUH019  
613-254-00-8forchlorfenuron (ISO);
1-(2-chloro-4-pyridyl)-3-phenylurea		-68157-60-8Carc. 2
Aquatic Chronic 2		H351
H411		GHS08
GHS09
Wng		H351
H411		   
613-255-00-3reaction mass of isomers of:
sodium [(2-hydroxyethylsulfamoyl) {[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl]
[2-(4-aminoethylpiperazine-1-yl) ethylsulfamoyl](sulfamoyl)}
(sulfonatophthalocyaninato)] copper(II)		424-270-8-Eye Dam. 1H318GHS05
Dgr		H318   
613-256-00-93'5'-anhydro thymidine425-810-538313-48-3Aquatic Chronic 3H412-H412   
613-257-00-42-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-?-alaninate426-400-9170222-39-6Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
613-258-00-Xreaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;
4-chloro-5-methylbenzotriazole sodium salt;
5-chloro-4-methylbenzotriazole sodium salt		427-730-6202420-04-0Skin Corr. 1B
Aquatic Chronic 3		H314
H412		GHS05
Dgr		H314
H412		   
613-259-00-5reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl
(1R)-cis-chrysanthemate;
[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate		428-790-672963-72-5Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1		H302
H400
H410		GHS07
GHS09
Wng		H302
H410		   
613-260-00-0(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy
(1-methyl-1H-imidazol-5-yl)methyl] -1-methyl-2(1H)-quinolin		430-730-9-Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H400
H410		GHS05
GHS09
Dgr		H318
H410		   
613-261-00-6pyrazole-1-carboxamidine monohydrochloride429-520-14023-02-3Acute Tox. 4 *
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H302
H373**
H318
H317
H412		GHS05
GHS08
GHS07
Dgr		H302
H373**
H318
H317
H412		   
613-262-00-1disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-
1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene		427-310-2180850-95-7Eye Dam. 1H318GHS05
Dgr		H318   
613-263-00-7monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate429-570-2-Skin Sens. 1H317GHS07
Wng		H317   
613-266-00-32-chloro-5-chloromethylthiazole429-830-5105827-91-6Acute Tox. 3 *
Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2		H311
H314
H302
H317
H411		GHS06
GHS05
GHS09
Dgr		H311
H314
H302
H317
H411		   
613-267-00-9thiamethoxam (ISO);
3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine		428-650-4153719-23-4Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1		H302
H400
H410		GHS07
GHS09
Wng		H302
H410		 M=10 
613-268-00-4(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine425-930-8151213-39-7Skin Corr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 2		H314
H332
H302
H373**
H411		GHS05
GHS08
GHS07
GHS09
Dgr		H314
H332
H302
H373**
H411		   
613-269-00-X2-thiazolidinylidenecyanamide427-720-126364-65-8Acute Tox. 4*
STOT RE 2 *
Aquatic Chronic 3		H302
H373**
H412		GHS08
GHS07
Wng		H302
H373**
H412		   
613-270-00-55-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide428-150-6113171-13-4Aquatic Chronic 3H412-H412   
613-271-00-0tritosulfuron (ISO) (containing > 0,02 % AMTT);
1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-
[2-(trifluoromethyl)benzenesulfonyl]urea (containing > 0,02 % AMTT)		-142469-14-5Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		 M=10 
613-272-00-6pyraclostrobin (ISO);
methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}
(N-methoxy)carbamate		--Acute Tox. 3 *
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1		H331
H315
H400
H410		GHS06
GHS09
Dgr		H331
H315
H410		 M=100 
613-273-00-1tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-
1,3,5-oxadiazinan-4-ylidene-N-nitroamine		427-600-9192439-46-6Aquatic Chronic 2H411GHS09H411   
613-274-00-72,6-dichloro-1-fluoropyridiniumtetrafluoroborate427-400-1140623-89-8Skin Corr. 1B
Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H314
H302
H317
H400
H410		GHS05
GHS07
GHS09
Dgr		H314
H302
H317
H410		   
613-275-00-23-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]
pyrimidin-4-one monohydrochloride		424-530-093076-03-0Acute Tox. 3 *
STOT SE 2
STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2		H301
H371**
H373**
H318
H317
H411		GHS06
GHS05
GHS08
GHS09
Dgr		H301
H371
H373**
H318
H317
H411		   
613-276-00-81-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one426-110-298377-35-6Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
613-277-00-3(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-
(4-methylphenyl)-1H-pyrazol-5-one		427-070-9-Aquatic Chronic 4H413-H413   
613-278-00-9(3-aminophenyl)pyridin-3-ylmethanone428-230-079568-06-2STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H373**
H400
H410		GHS08
GHS09
Wng		H373**
H410		   
613-279-00-42-ethyl-2,3-dihydro-2-methyl-1H-perimidine424-380-643057-68-7Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H302
H373**
H400
H410		GHS08
GHS07
GHS09
Wng		H302
H373**
H410		   
613-280-00-Xtetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;
dimethyl propyleneurea		230-625-67226-23-5Repr. 2
Acute Tox. 4 *
Eye Dam. 1		H361f***
H302
H318		GHS05
GHS08
GHS07
Dgr		H361f***
H302
H318		   
613-281-00-5quinoline202-051-691-22-5Carc. 1B
Muta. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2		H350
H341
H312
H302
H319
H315
H411		GHS08
GHS07
GHS09
Dgr		H350
H341
H312
H302
H319
H315
H411		   
613-282-00-0triticonazole (ISO);
(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-
(1H-1,2,4-triazol-1-methyl)cyclopentanol		-131983-72-7Aquatic Chronic 2H411GHS09H411   
613-283-00-6ketoconazole;
1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-
1,3-dioxolan-4-yl] methoxy]phenyl]piperazin-1-yl] ethanone		265-667-465277-42-1Repr. 1B
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H360F***
H301
H373**
H400
H410		GHS06
GHS08
GHS09
Dgr		H360F***
H301
H373**
H410		   
613-284-00-1metconazole (ISO);
(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-
(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol		-125116-23-6Repr. 2
Acute Tox. 4 *
Aquatic Chronic 2		H361d***
H302
H411		GHS08
GHS07
GHS09
Wng		H361d***
H302
H411		   
613-285-00-71-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2]		219-989-7 [1]
219-989-7 [2]		2592-95-2 [1]
123333-53-9 [2]		Expl. 1.3H203GHS01
Dgr		H203   
613-286-00-2potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-
5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)]		418-260-2183196-57-8Skin Sens. 1H317GHS07
Wng		H317   
613-286-01-Xpotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-
5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing > 0,5 % N,N-dimethylformamide (EC No 200-679-5)]		418-260-2183196-57-8Repr. 1B
Skin Sens. 1		H360D***
H317		GHS08
GHS07
Dgr		H360D***
H317		   
613-287-00-81-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole419-540-7160194-26-3Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2		H302
H317
H411		GHS07
GHS09
Wng		H302
H317
H411		   
613-288-00-31,3-bis(dimethylcarbamoyl)-imidazolium chloride420-930-4135756-61-5Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3		H302
H318
H412		GHS05
GHS07
Dgr		H302
H318
H412		   
613-289-00-93-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole432-020-4142623-48-1Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
613-290-00-44-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride432-470-1189012-93-9Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H317
H400
H410		GHS05
GHS07
GHS09
Dgr		H318
H317
H410		   
613-291-00-X2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-
(1-methylpropyl)-3H-1,2,4-triazol-3-one		434-820-9106461-41-0STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H373**
H400
H410		GHS08
GHS09
Wng		H373**
H410		   
613-292-00-5N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine435-010-826157-73-3Muta. 2
Aquatic Chronic 3		H341
H412		GHS08
Wng		H341
H412		   
613-293-00-02-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)
carbamoyloxy]-1H-pyrrolo[1,2-b] [1,2,4] triazole-7-carboxylic
acid 2,6-di-tert-butyl-4-methylcyclohexylester		448-050-6444065-11-6Aquatic Chronic 4H413-H413   
613-294-00-62-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo [1,5-b]
[1,2,4]triazol-2-yl) phenylcarbamoyl]methylester		448-260-8379268-96-9Aquatic Chronic 4H413-H413   
613-295-00-111-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f]
[1,2]thiazepine hydrochloride		448-720-8363138-44-7Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3		H302
H318
H412		GHS05
GHS07
Dgr		H302
H318
H412		   
613-296-00-7pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-
methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-
3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate		418-270-7-Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
613-297-00-25-(2-bromophenyl)-2-tert-butyl-2H-tetrazole420-820-6-Flam. Liq. 3
Acute Tox. 4 *
Aquatic Chronic 2		H226
H302
H411		GHS02
GHS07
GHS09
Wng		H226
H302
H411		   
613-298-00-8bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-
1H-pyridin-2-one)ethylene dilactate		421-560-6-STOT RE 2 *
Eye Dam. 1
Aquatic Chronic 2		H373**
H318
H411		GHS05
GHS08
GHS09
Dgr		H373**
H318
H411		   
613-299-00-3main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-
4-hydroxy-2-sulfonapht-7-ylamino]- 1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-
[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-
1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-
4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-
[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-
1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-
hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-
hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt		422-610-1-Eye Dam. 1H318GHS05
Dgr		H318   
613-300-00-71-imidazol-1-yl-octadecan-2-ol434-120-3-Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
613-301-00-2dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[
2-octadecyl-1,1-dioxo- 1,2,4-benzothiadiazin-3-yl]methyl}
imidazole-4,5-dicarboxylate		443-910-7-Aquatic Chronic 4H413-H413   
613-302-00-8disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6
-oxo-1,6-dihydro-pyridine-3-ylazo)-
4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-
1,3,5-triazine-2-ylamino)benzene sulfonate		432-980-4243858-60-8Eye Dam. 1H318GHS05
Dgr		H318   
613-303-00-32-(1-methyl-2-(4-phenoxyphenoxy) ethoxy)pyridine429-800-195737-68-1Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
613-304-00-95,6-dihydroxy-2,3-dihydro-1H-indolium bromide421-170-6138937-28-7Acute Tox. 4 *
Eye Dam. 1		H302
H318		GHS05
GHS07
Dgr		H302
H318		   
613-305-00-42-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole448-630-93147-77-1Aquatic Chronic 4H413-H413   
613-306-00-X(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate433-520-582911-69-1Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 2		H302
H317
H411		GHS07
GHS09
Wng		H302
H317
H411		   
613-307-00-5clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine		-210880-92-5Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1		H302
H400
H410		GHS07
GHS09
Wng		H302
H410		 M=10 
613-308-00-02-amino-5-methylthiazole423-800-57305-71-7Acute Tox. 4 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1		H302
H373**
H400
H410		GHS08
GHS07
GHS09
Wng		H302
H373**
H410		   
613-309-00-61-methyl-3-phenyl-1-piperazine431-180-25271-27-2Acute Tox. 4 *
Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Chronic 3		H312
H302
H315
H318
H412		GHS05
GHS07
Dgr		H312
H302
H315
H318
H412		   
613-310-00-1(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-
N-benzylpiperidine hydrochloride		432-360-3105813-13-6Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H317
H400
H410		GHS07
GHS09
Wng		H302
H317
H410		   
613-311-00-7methyl-5-nitrophenyl-guanidine435-500-1152460-07-6Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3		H302
H319
H317
H412		GHS07
Wng		H302
H319
H317
H412		   
613-312-00-22-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride420-200-5-Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H302
H318
H317
H412		GHS05
GHS07
Dgr		H302
H318
H317
H412		   
613-313-00-82-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3 (2H)-dione442-780-9173838-67-0Aquatic Chronic 3H412-H412   
613-314-00-34-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one		443-770-77693-82-5Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
613-315-00-9tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-
sulfonatophenyl)pyrazol-4-ylidene]-
3-(piperidinocarbonyl)penta-1,3-dienylidene] -5-hydroxy-1-(
4-sulfonatophenyl)pyrazole-3-carboxylate		430-390-1-Acute Tox. 4 *
Aquatic Chronic 3		H332
H412		GHS07
Wng		H332
H412		   
613-316-00-4trimethylopropane tri(3-aziridinylpropanoate);
(TAZ)		257-765-052234-82-9Muta. 2
Eye Dam. 1
Skin Sens. 1		H341
H318
H317		GHS05
GHS08
GHS07
Dgr		H341
H318
H317		  H
615-033-00-1reaction product of diphenylmethanediisocyanate, octylamine,
oleylamine and cyclohexylamine (1:1.58:0.32:0.097)		430-980-9-Aquatic Chronic 4H413-H413   
615-034-00-7reaction product of diphenylmethanediisocyanate, octylamine,
4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)		430-750-8-Aquatic Chronic 4H413-H413   
615-035-00-2reaction product of diphenylmethanediisocyanate, octylamine and oleylamine
(molar ratio 1:1.86:0.14)		430-930-6122886-55-9Aquatic Chronic 4H413-H413   
615-036-00-8reaction product of diphenylmethanediisocyanate, toluenediisocyanate
(reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine,
oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)		430-940-0-Aquatic Chronic 4H413-H413   
615-037-00-3reaction product of diphenylmethanediisocyanate, toluenediisocyanate
(reaction mass of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate),
octylamine and oleylamine (molar ratio 4:1:9:1)		430-950-5-Aquatic Chronic 4H413-H413   
615-038-00-9reaction product of toluenediisocyanate (reaction mass of isomers:
65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)		430-960-1-Aquatic Chronic 4H413-H413   
615-039-00-4reaction product of diphenylmethanediisocyanate, toluenediisocyanate
(reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate),
octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)		430-970-4-Aquatic Chronic 4H413-H413   
615-044-00-14-chlorophenylisocyanate203-176-9104-12-1Acute Tox. 2 *
Acute Tox. 4 *
STOT SE 3
Skin Irrit. 2
Eye Dam. 1
Resp. Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H330
H302
H335
H315
H318
H334
H400
H410		GHS06
GHS05
GHS08
GHS09
Dgr		H330
H302
H335
H315
H318
H334
H410		   
615-045-00-74,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)420-530-1-Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 4		H334
H317
H413		GHS08
Dgr		H334
H317
H413		   
616-107-00-6cinidon ethyl (ISO);
ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate		-142891-20-1Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H351
H317
H400
H410		GHS08
GHS07
GHS09
Wng		H351
H317
H410		   
616-122-00-8methyl-neodecanamide414-460-9105726-67-8Acute Tox. 4 *H302GHS07
Wng		H302   
616-126-00-X1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide423-960-6139756-01-7Acute Tox. 4 *
STOT RE 2 *
Aquatic Chronic 3		H302
H373**
H412		GHS08
GHS07
Wng		H302
H373**
H412		   
616-131-00-71-aminocyclopentanecarboxamide422-950-917193-28-1STOT RE 1
Acute Tox. 4 *
Eye Dam. 1		H372**
H302
H318		GHS05
GHS08
GHS07
Dgr		H372**
H302
H318		   
616-136-00-4reaction product of cocoalkyldiethanolamides and
cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)		430-380-7-Aquatic Chronic 2H411GHS09H411   
616-137-00-X4-dichloroacetyl-1-oxa-4-azaspiro [4,5]decane401-130-471526-07-3Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
616-138-00-5benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide431-600-4112226-61-6Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
616-139-00-0(3S,4aS,8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide420-380-5136465-81-1Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 3		H302
H318
H412		GHS05
GHS07
Dgr		H302
H318
H412		   
616-140-00-6N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]429-380-1133336-92-2Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
616-141-00-1zoxamide (ISO);
(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide		-156052-68-5Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H317
H400
H410		GHS07
GHS09
Wng		H317
H410		 M=10 
616-144-00-83,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]
butyramido]-2-hydroxyphenyl]benzamide		431-130-1-Aquatic Chronic 4H413-H413   
616-145-00-3pethoxamide (ISO);
2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide		-106700-29-2Acute Tox. 4 *
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H302
H317
H400
H410		GHS07
GHS09
Wng		H302
H317
H410		 M=100 
616-146-00-9N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-
dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide		431-330-7142776-95-2Aquatic Chronic 4H413-H413   
616-147-00-41-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide424-160-1139481-22-4Acute Tox. 4 *
Aquatic Chronic 3		H302
H412		GHS07
Wng		H302
H412		   
616-148-00-XN-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-
6-oxo-1H-purin-2-yl]acetamide		424-550-184245-12-5Carc. 1B
Muta. 1B
Repr. 1B		H350
H340
H360FD		GHS08
Dgr		H350
H340
H360FD		   
616-150-00-0(2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-
4-nitrobenzenesulfonamide hydrochloride		425-260-6-STOT RE 2 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2		H373**
H318
H317
H411		GHS05
GHS08
GHS07
GHS09
Dgr		H373**
H318
H317
H411		   
616-151-00-6N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide425-650-6171887-03-9Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3		H302
H318
H317
H412		GHS05
GHS07
Dgr		H302
H318
H317
H412		   
616-152-00-14-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3, N-diphenylbutanamide425-850-3125971-96-2Aquatic Chronic 4H413-H413   
616-153-00-74-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide425-860-8125971-57-5Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
616-154-00-23,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]
butyramido]-2-hydroxyphenyl]benzamide		431-110-0-Aquatic Chronic 4H413-H413   
616-155-00-8N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide431-040-0104560-40-9Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
616-156-00-36-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-
[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino] acetanilide		430-500-8204277-61-2Aquatic Chronic 4H413-H413   
616-157-00-93-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride427-780-9114565-70-7Acute Tox. 4 *
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic		H302
H318
H400
H410		GHS05
GHS07
GHS09
Dgr		H302
H318
H410		   
616-158-00-4N-[4-cyano-3-trifluoromethylphenyl]methacrylamide427-880-290357-53-2STOT RE 2 *
Aquatic Chronic 2		H373**
H411		GHS08
GHS09
Wng		H373**
H411		   
616-160-00-52,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]429-090-361551-69-7Skin Sens. 1
Aquatic Chronic 3		H317
H412		GHS07
Wng		H317
H412		   
616-161-00-02,4-dichloro-5-hydroxyacetanilide429-110-067669-19-6Aquatic Chronic 3H412-H412   
616-162-00-6isostearic acid monoisopropanolamide431-540-9-Skin Irrit. 2
Aquatic Chronic 2		H315
H411		GHS07
GHS09
Wng		H315
H411		   
616-163-00-14,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]430-350-3192463-88-0Aquatic Chronic 4H413-H413   
616-164-00-7dimoxystrobin (ISO);
(E)-2-(methoxyimino)-N-methyl-2-[?-(2,5-xylyloxy)-o-tolyl]acetamide		-149961-52-4Carc. 2
Repr. 2
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1		H351
H361d***
H332
H400
H410		GHS08
GHS07
GHS09
Wng		H351
H361d***
H332
H410		 M=10 
616-165-00-2beflubutamid (ISO);
(RS)-N-benzyl-2-(?,?,?,4-tetrafluoro-m-tolyoxy)butyramide		-113614-08-7Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410 M=100 
616-166-00-8cyazofamid (ISO);
4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide		-120116-88-3Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410 M=10 
616-167-00-3N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide418-290-6168612-06-4Eye Irrit. 2
Skin Sens. 1		H319
H317		GHS07
Wng		H319
H317		   
616-168-00-91-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium418-440-0136997-71-2Skin Sens. 1H317GHS07
Wng		H317   
616-169-00-44-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-
(2-(3-pentadecylphenoxy)butylamido) anilino)-1-
(2,4,6-trichlorophenyl)-2-pyrazoline-5-one		420-220-492771-56-7Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
616-170-00-X(2R)-2-amino-2-phenylacetamide420-370-06485-67-2Eye Irrit. 2
Skin Sens. 1		H319
H317		GHS07
Wng		H319
H317		   
616-171-00-52-(para-chlorophenyl)glycineamide420-830-0102333-75-5Eye Dam. 1
Skin Sens. 1		H318
H317		GHS05
GHS07
Dgr		H318
H317		   
616-172-00-0N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;
(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl		423-840-314691-89-5Acute Tox. 4 *H302GHS07
Wng		H302   
616-174-00-12-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride424-560-4151257-01-1Acute Tox. 4 *
Eye Irrit. 2		H302
H319		GHS07
Wng		H302
H319		   
616-175-00-72-(2-hexyldecyloxy)benzamide431-230-3202483-62-3Aquatic Chronic 4H413-H413   
616-176-00-23-N,N-bis(methoxyethyl) aminoacetanilide432-530-724294-01-7Acute Tox. 4 *
Aquatic Chronic 3		H302
H412		GHS07
Wng		H302
H412		   
616-177-00-8(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino) phenylthio)-5-oxo-1-
(2,4,6-trichlorophenyl)- 4,5-dihydro-1H-pyrazole-3-ylamino)-4-
chlorophenyl)tetradecanamide;
N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino} phenyl)thio]-5-oxo-
1-(2,4,6-trichlorophenyl)-4,5-dihydro-
1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide		432-970-1217324-98-6Aquatic Chronic 4H413-H413   
616-178-00-3N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-
azo)phenyl)acetamide		434-500-952583-35-4Aquatic Chronic 4H413-H413   
616-179-00-92-chloro-N-(4-methylphenyl)acetamide435-170-916634-82-5Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1		H318
H317
H400
H410		GHS05
GHS07
GHS09
Dgr		H318
H317
H410		   
616-180-00-4N,N-(dimethylamino)thioacetamide hydrochloride435-470-127366-72-9Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1		H360D***
H400
H410		GHS08
GHS09
Dgr		H360D***
H410		   
616-181-00-X4'-methyldodecane-1-sulfonanilide435-490-917417-32-2Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
616-182-00-5N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide435-860-1214417-91-1Skin Sens. 1
Aquatic Chronic 2		H317
H411		GHS07
GHS09
Wng		H317
H411		   
616-183-00-0N-dodecyl-4-methoxybenzamide442-340-61854-15-5Aquatic Chronic 4H413-H413   
616-184-00-63-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide442-560-2105043-55-8Aquatic Chronic 4H413-H413   
616-186-00-7N,N'-(2-chloro-1,4-phenylene)bis (3-oxobutaneamide)443-010-453641-10-4Aquatic Chronic 3H412-H412   
616-188-00-82-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-
(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide		443-980-9221215-20-9Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
616-189-00-3N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-
dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide		444-780-4452962-97-9Aquatic Chronic 4H413-H413   
616-190-00-9N-decyl-4-nitrobenzamide445-880-064026-19-3Aquatic Chronic 4H413-H413   
616-191-00-42-ethyl-N-methyl-N-(3-methylphenyl)butanamide446-190-2406488-30-0Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2		H302
H319
H315
H317
H411		GHS07
GHS09
Wng		H302
H319
H315
H317
H411		   
616-192-00-X2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2- (5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide448-060-0727678-39-9Aquatic Chronic 4H413-H413   
616-193-00-5N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-
ylazo)-5-diethylamino-phenyl]acetamide		449-940-7368450-39-9Aquatic Chronic 4H413-H413   
616-194-00-02,2-diethoxy-N,N-dimethylacetamide449-950-134640-92-1Eye Irrit. 2H319GHS07
Wng		H319   
616-196-00-1disodium salt of 1-hydroxy-4-(?-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-
naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide		419-990-4-Aquatic Acute 1
Aquatic Chronic 1		H400
H410		GHS09
Wng		H410   
616-197-00-7reaction mass of:
potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-
heptadecafluorooctane sulfonamidate;
N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-
heptadecafluorooctane sulfonamide		422-500-1-STOT RE 2 *H373**GHS08
Wng		H373**   
616-198-00-21,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene423-300-7-Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
616-200-00-1reaction mass of: N,N'-ethane-1,2-diylbis(hexanamide);
12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;
N,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide)		432-430-3-Skin Sens. 1
Aquatic Chronic 4		H317
H413		GHS07
Wng		H317
H413		   
616-201-00-712-hydroxyoctadecanoic acid, reaction products with
1,3-benzenedimethanamine and hexamethylenediamine		432-840-2220926-97-6Acute Tox. 4 *
Aquatic Chronic 4		H332
H413		GHS07
Wng		H332
H413		   
616-202-00-2reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis
[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo] [1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;
2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo] [1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide		434-330-5-Carc. 2
Skin Sens. 1
Aquatic Chronic 4		H351
H317
H413		GHS08
GHS07
Wng		H351
H317
H413		   
616-203-00-8reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-
dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;
N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)
5-diethylaminophenyl]acetamide		442-280-0-Aquatic Chronic 4H413-H413   
616-204-00-3N,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]451-060-3122886-55-9Aquatic Chronic 4H413-H413   
617-021-00-1methylethylketone peroxide trimer429-320-2-Org. Perox. B****
Asp. Tox. 1
Skin Irrit. 2
Skin Sens. 1		H241
H304
H315
H317		GHS01
GHS02
GHS08
GHS07
Dgr		H241
H304
H315
H317		   
617-022-00-7reaction mass of: 1,2-dimethylpropylidene dihydroperoxide;
dimethyl 1,2-benzenedicarboxylate		442-480-8-Org. Perox. C
Acute Tox. 4 *
Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2		H242
H302
H314
H317
H411		GHS02
GHS05
GHS07
GHS09
Dgr		H242
H302
H314
H317
H411		   
647-017-00-5laccase420-150-480498-15-3Resp. Sens. 1H334GHS08
Dgr		H334   


 weiter .Frame öffnen